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Herpes simplex virus type-1 (HSV-1) infection results in the establishment of a latent infection 
in sensory ganglia of the peripheral nervous system (PNS).   In humans the virus can 
sporadically reactivate and gain access to the primary sites of infection and cause considerable 
tissue damage.  The mechanisms involved in establishment and maintenance of latency and the 
sporadic reactivation of HSV-1 infected neurons in sensory ganglia is poorly defined. 
Elucidating the mechanisms involved in maintenance of latency of HSV-1 would be extremely 
valuable in controlling the high prevalence of disease in communities around the world.  We 
have shown that CD8+ T lymphocytes can block HSV-1 reactivation from latency in sensory 
neurons of the trigeminal ganglion ex vivo.   
The mechanism that the CD8+ T cells employ to prevent reactivation includes release of 
the antiviral cytokine IFNγ, but other mechanisms, such as the lytic effect of perforin and 
granzymes appear to be important as well.  In order to further understand the cellular immune 
response against the latent HSV infection we have attempted to dissect the CD8+ T cell immune 
response in the TG during acute and latent infection.  Specifically, we determined the antigen 
specificity and TCR expression of the CD8+ T cells that accumulate in the TG at various times 
post infection. We have investigated the state of CD8+ T cell memory after HSV-1 infection and 
clarified the mechanisms used by CD8+ T cells to prevent reactivation from latency 
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CD8, gB-specific TCR and incorporated BrdU.  Total number of CD8  T cells that were 
BrdU positive (BrdU CD8 ), gB-dimer positive CD8 T cells that were BrdU positive 
(BrdU CD8 gB ), and gB-dimer negative CD8 T cells that were BrdU positive 
(BrdU CD8 gB ) are shown.
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Figure 43: Apoptotic potential of CD8  T cells in the TG at 8 days after HSV-1 corneal 
infection.  Apoptosis of ganglionic CD8  T cells from the indicated groups of mice was 
determined by annexin-V binding.
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Figure 44: Apoptotic potential of CD8  T cells in the LN at 8 days after HSV-1 corneal 
infection.  Apoptosis of Lymphoid CD8  T cells from the indicated groups of mice was 
determined by annexin-V binding.  Histogram demonstrating the intensity of annexin-V 
binding on lymphoid CD8  T cells isolated from anti-IL-2 treated (1mg at day 6PI) IL-15   
(red lines) and WT untreated (black lines) at 8 days PI (A). Each line in the histogram 
represents 1 mouse with n=3 for each group.  Percentage of annexin-V positive CD8  T 
cells in the LN of the indicated groups of mice at 8 days PI (B).  Significance of differences 
between anti-IL-2 treated IL-15  mice and all indicated groups were determined by one 
way ANOVA (non-parametric) analysis with Bonferroni post test comparing all groups 
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together. *P<0.01, error bars indicate mean percent ± SEM. For all indicated groups n=3.
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Figure 45: IL-15 is required for the maintenance of viral specific memory CD8  T cells.  
C57BL6 mice were treated with 1mg control (WT) or 1mg anti-IL-2 antibody (WT anti-IL-
2).  IL-15  mice were were treated with 1mg control (IL-15-KO) or 1mg anti-IL-2 antibody 
(IL-15-KO anti-IL-2) at 6 days PI.  Mice were sacrificed at 65 days PI, Single-cell 
suspensions of TG and spleen were stained for CD8, and gB-specific TCR.  The data shows 
total of number of gB-specific CD8  T cells cells per TG or 1.5 x 10  spleen cells. Error 
bars indicate mean percent ± SEM. For all indicated groups n=3.
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Figure 46: IL-15 is required for the maintenance of non-lymphoid memory CD4  T cells.  
C57BL6 mice were treated with 1mg control (WT) or 1mg anti-IL-2 antibody (WT anti-IL-
2).  IL-15  mice were were treated with 1mg control (IL-15-KO) or 1mg anti-IL-2 antibody 
(IL-15-KO anti-IL-2) at 6 days PI.  Mice were sacrificed at 65 days PI, Single-cell 
suspensions of TG and spleen were stained for CD4, and CD45.  The data shows total of 
number of CD4  T cells cells per TG (A) or 1.5 x 10  spleen cells (B). Error bars indicate 
mean percent ± SEM. For all indicated groups n=3.
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Figure 47: Summary of events in the TG.  After HSV-1 infection, CD8  T cells go through the 
typical expansion and contraction phase in the TG.  By day 34 PI a stable pool of memory 
CD8  T cell is established.  Anti IL-2 treated mice (at day 6 PI) have a reduced expansion 
phase, but form a normal memory CD8  T cell pool.  IL-15  mice have a reduced 
expansion phase and fail to form a normal memory CD8  T cell population.
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Figure 48: Summary of events in the lymphoid organs. After HSV-1 corneal infection, CD8  T 
cells in the LN go through the typical expansion and contraction phase.  By day 34 PI a 
stable pool of memory CD8  T cell is established.  Anti IL-2 treated mice (at day 6 PI) go 
through a normal expansion phase, as well as form a normal memory CD8  T cell pool.  IL-
15  mice have a reduced expansion phase, and fail to form a normal memory CD8  T cell 
population in the spleen.
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Figure 49: Model of immune surveillance during HSV-1 latency and reactivation. .................. 122 
Figure 50: CD8  T cell infiltrate found in human TGs of individuals infected with HSV-1.  
Paraffin embedded human TGs (kindly provided by Dr. Y. Jerold Gordon) were stained 
with purified anti-human CD8, followed by biotin-conjugated secondary antibody.  Horse 
raddish peroxidase ABC kit was used to detect the secondary antibody.  Note that many 
CD8  T cells (arrows) are in close apposition to neuronal cell bodies (white arrow heads).  
We also noticed clusters of T cells surrounding neurons in a few field of views (right 
pictogram); perhaps indicating a reactivation event.
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 1. INTRODUCTION 
 
1.1. Herpes Simplex Virus   
Herpes Simplex viruses (HSV) are one of the most widely studied viruses in the world. 
The name herpes comes from the Greek word ‘herpein’, which means to creep. Like other 
herpesviruses, they have very unique biological properties, particularly their ability to form latent 
infections and reactivate periodically to cause herpetic lesions.  Herpes Simplex Virus 1 (HSV-1) 
is an alphaherpes virus, which is part of a large family of viruses collectively called the 
herpesviridae.  This thesis will primarily explore the dynamic equilibrium of HSV-1 infection 
involving a tripartite interaction between the virus, the host neuron and the local immune 
components. 
1.2. Viral Structure 
The HSV virion (Figure 1) is approximately 200 nm in diameter and is made up of four 
basic elements: (i) a core that contains a spool around which the double stranded DNA (dsDNA) 
is wrapped; (ii) an icosahedral capsid made up of 162 hexagonal capsomeres and five viral 
proteins surrounding the core and is 100-110 nm in diameter; (iii) A tegument surrounds the 
capsid and contains viral proteins that are critical for initiating viral gene expression; and (iv) an 
outer envelope, which is a lipid bilayer and contains numerous embedded glycoproteins (1).    
1.3. Viral genome 
The viral genome, when in the virion, comprises of a linear double stranded DNA 
approximately 153,000 base pairs (bp) in length.  The genome is organized into two main 
segments of long (L) and short (S) domains (Figure. 2).  The genome contains two unique 
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Figure 1: Electron micrograph (left) and a schematic (right) of HSV-1 structure showing the 
four basic components of the virion. 
 
regions unique long (UL) and unique short (US). There are short inverted repeats between and 
flanking the unique sequences L and S denoted as LTRa, LTRb, and LTRc.  The genome is 
represented by a particular scheme in which the first nucleotide of the shortest terminal repeat is 
LTRa, adjacent to LTRb followed by the UL region, LTRa’,b’ and LTRc’ and ending with LTRc 
and LTRa,  as shown in Figure. 2.  The viral genome may contain variable number of LTRa 
copies (2,1). 
 
 
 
 
 
 
 
 
Figure 2: Schematic illustration of the arrangement of DNA in the HSV-1 genome. (Figure 
not to scale)  
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 1.4. HSV-1 infection and gene expression 
The HSV-1 genome encodes more than 80 unique proteins that are expressed in a 
regulated and sequential manner (Figure. 4).  There are three main classes of gene transcripts 
encoded by HSV-1 DNA; immediate early genes (α proteins), early genes (β proteins) and late 
genes that are further divided into γ1 and γ2 genes.   
1.4.1. Viral life cycle 
One of the unique properties of HSV-1 is its ability to virtually infect all types of 
mammalian cells.  The infection begins (Figure. 3) when the virus attaches to the myriad of 
extracellular matrix proteins such as heparan sulfate on the cell surface.  Viral proteins involved 
in the initial attachment process are primarily gB and gC.  The second step in the attachment 
process involves the binding of viral protein gD with many coreceptors on the cell, including 
members of the tumor necrosis factor (TNF) receptor family, and immunoglobulin (Ig) 
superfamily.  After the interaction of gD with cellular coreceptors the viral envelope fuses with 
the plasma membrane, an event mediated by glycoproteins gB, gD, and gH.  After the fusion of 
the viral envelope with the plasma membrane, the capsid with the tegument proteins along with 
the viral DNA is released in the cytoplasm and the viral glycoproteins remain embedded at the 
surface of the cell.  The viral nucleocapsid and certain tegument proteins (VP16) are transported 
to the nucleus. The virus docks at the nuclear pores and releases the viral DNA inside the 
nucleus.  Upon release into the nucleus VP16 interacts with host transcription factors to initiate 
the expression of immediate early (α) genes (without new viral protein synthesis), which in turn 
activate early (β) genes that mediate DNA replication of HSV genome.  Expression of β and γ1 
genes require α protein expression. 
3 
 α proteins β proteins 2
1
Cytoplasm 
Egress?
α RNA β RNA γ RNA 
DNA replication 
γ proteins
Nucleus 
VP16 
HSV-1 Life Cycle 
 
Figure 3: Schematic representation of the HSV-1 life cycle.  
 
Following DNA synthesis γ1 gene transcription is augmented and γ2 gene expression 
commences (γ2 gene expression requires the onset of DNA synthesis).  After late proteins are 
translated in the cytoplasm the premature glycoproteins are localized to the inner and outer 
membrane of the cell’s nuclear membrane.  These proteins are further modified in the Golgi 
apparatus and the mature glycoproteins are then transported to the plasma cell membrane.  There 
are two proposed pathways by which the virus egresses from the infected cell (Figure 3). The 
first pathway shows (Pathway 1 in Figure 3) the virus buds out of the inner nuclear membrane 
and fuses with the outer nuclear membrane and in the process is de-enveloped and transported 
through the Trans Golgi apparatus, where it acquires its envelope and egresses out through the 
plasma membrane. In the second pathway (Pathway 2 in Figure 3) the virus buds off the outer 
nuclear membrane with an intact envelope and is transported to the plasma membrane of the cell 
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 where it egresses out of the cell.  A recent study by Grunewald et.al (3) now favors the first 
pathway. 
1.4.2. HSV-1 lytic infection and gene expression 
Immediate Early (α) Gene Expression: HSV-1 infection of non-neuronal cells 
usually leads to the death of the host cell.  In most cells, HSV-1 produces a lytic infection in 
which it expresses its entire genome with the exception of latency associated transcripts (LAT).  
During lytic infection viral gene expression is remarkably regulated (Figure. 4).  Viral tegument 
protein VP16 augments α gene expression by interacting with two other cellular proteins by 
binding to a target sequence TAATGARAT.  This results in the expression of five α gene 
products ICP4, ICP0, ICP27, ICP47 and ICP22 (4).  α Gene expression peaks between two to 
four hours after infection. 
ICP4 is an essential viral α protein that serves as a transcription factor to activate early 
and late proteins (5).  ICP4 can also serve as a repressor, inhibiting the expression of immediate-
early genes (6).  ICP0 is a non-essential protein but can activate viral gene expression at low 
multiplicity of infection (MOI).  ICP0 is essential for efficient reactivation of HSV-1 from 
latency (7).  ICP0 localizes to the nucleus where it can influence chromatin structure by breaking 
down histone proteins and other nuclear proteins such as nuclear domain 10 (ND10) bodies 
(8,9,10).  The ability of ICP0 to influence viral and host cell chromatin structure and accessibility 
of transcription factors to viral and host cell DNA makes it a good candidate for regulating 
reactivation (11). ICP0 has also been shown to inactivate interferon associated gene cascade, 
thus implicating it in immune evasion (12,13). 
ICP27 is an essential α protein required for HSV-1 lytic infection and essential for early 
and especially late gene expression.  ICP27 has myriad of functions; (14,1) it regulates splicing, 
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 translation and post-translational modification of viral gene expression.  ICP27 localizes to the 
nucleus and regulates the nuclear transport of viral mRNA transcripts. ICP27 also controls host 
cell gene expression by interacting with small nuclear ribonucleoprotein particles (snRNPs) and 
inhibiting host cell mRNA splicing (15). 
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Figure 4: HSV-1 gene expression during lytic infection.  The x-axis denotes time after infection 
of a cell by HSV-1.  The y-axis represents level of α, β, and γ gene expression. The dotted blue 
line represents DNA synthesis. Note that γ1 genes can be expressed in the absence of DNA 
synthesis but are elevated substantially after the onset of DNA replication. Note that this figure 
only denotes general chronology of events. 
 
ICP47 is not an essential protein for viral lytic infection but plays a very important role in 
immune evasion.  ICP47 is a soluble 12-kDa protein that effectively blocks antigen presentation 
of viral peptides by blocking the transporter associated with antigen processing (TAP) complex.  
TAP1 and 2 are encoded by the major histocompatibility complex (MHC) cluster and play a 
crucial role in the endogenous antigen presentation pathway by which viral antigens are 
presented to CD8+ T cells in the context of MHC class I molecules (16).  Viral proteins are 
processed into small peptides by the proteasomes in the cytosol and subsequently transported 
into the lumen of the endoplasmic reticulum (ER), where they bind to the MHC class I molecules 
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 to be presented at the surface of the infected cell.  TAP1 and TAP2 form a non-covalent complex 
at the surface of the ER and facilitate the shuttling of viral peptides from the cytosol to the ER 
(17).  Residues 2-35 of ICP47 prevent the transport of viral peptides by binding to the TAP1 and 
TAP2 molecules and weakening the interaction between the two molecules, thus precluding 
efficient activation of HSV specific cytotoxic T lymphocytes (CTL) (18). ICP47 is especially 
effective in blocking human TAP, but a recent study showed that it can also inhibit murine TAP 
function (19).   
The fifth IE gene product ICP22 is not essential for viral replication but is important in 
the expression of ICP0 and some late genes (14).   
Early (β) Gene Expression: Soon after the synthesis of α proteins, β genes are expressed.  
Early genes are primarily involved in DNA replication (20). β Gene expression begins as early as 
three hours after infection and reaches its peak between four and seven hours post infection (PI).  
DNA replication begins upon β protein expression and continues for up to fifteen hours PI.  
One of the β gene products thymidine kinase (TK) is not required for viral DNA 
synthesis in non-neuronal cells because the virus is able to employ cellular TK; however it is 
essential for viral replication in neuronal cells because neurons do not contain their own TK.  For 
this reason, virus lacking TK is unable to reactivate once it establishes latency in ganglionic 
neurons (21,22).  HSV TK can phosphorylate purine nucleosides and deoxyribonucleosides in 
addition to thymidine.  Guanosine analogs acyclovir and gancyclovir are prodrugs that have been 
effectively used for many years to combat herpetic infections.  Acyclovir is only effective in 
HSV infected cells because it requires a triple kinase activity to be converted into a triphosphate 
derivative, which can then serve as a substrate for HSV-1 DNA polymerase.  Once the 
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 triphosphate acyclovir derivative is incorporated into the HSV DNA, the growing DNA chain 
terminates since acyclovir lacks the 3’ OH sugar group(20). 
Late (γ) Gene Expression:  The viral late genes are subdivided into γ1 and γ2 genes.  γ1, 
also called leaky genes, are expressed at low levels before viral DNA synthesis (Figure. 4), but at 
much higher levels after viral DNA synthesis is initiated.   Expression of γ2 genes is completely 
dependent on initiation of viral DNA synthesis.  Some of the γ1 genes include structural proteins 
such as glycoprotein B (gB) and glycoprotein D (gD).  γ2 Genes encode for proteins such as gC, 
gH, US11, and US9.  The exact mechanisms that direct late gene expression are not well 
understood, however α and β genes such as ICP4, ICP27 and ICP8 are necessary for late gene 
expression (6, 1,14).  After the onset of DNA synthesis late genes that encode structural proteins 
are expressed in considerably high levels to ensure the generation of high numbers of infectious 
viral progenies. 
1.4.3. Effect on the Host Cell after HSV-1 Productive Infection 
 
HSV-1 is an exceptionally cytopathic virus; cells productively infected with HSV 
undergo substantial changes, which ultimately lead to their death.  The molecular, chemical and 
structural changes that occur in the productively infected epithelial cell are extensive therefore, 
only an overview will be provided.  For a broader and excellent discussion please see reference 
1.  Upon infection of an epithelial cell by HSV-1, viral glycoproteins are embeded in the cellular 
membrane.  Once HSV-1 productive infection proceeds, the microtubular structure of the host 
cell is disrupted and the Golgi apparatus is fragmented leading to the rounding up and adherence 
of infected cells.  One of the most detrimental effect of HSV infection is the shut off of host 
DNA, RNA and protein synthesis.  Host mRNA and proteins are degraded and transcriptional 
and translational processes are completely inhibited.  Viral tegument protein called the virion 
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 host shut-off protein (vhs) is largely responsible for initiating and carrying out the host shut off 
processes (14).  Another profound effect of HSV-1 infection is on the host cell cycle machinery 
(1).  Since the virus shuts off host DNA synthesis there is an indirect block in the cell cycle at the 
G1 phase.  HSV infection also leads to inhibition of cyclin dependent kinases (CDK) such as 
cdk2 and cyclin D3 proteins.  However recent studies have implicated certain CDKs in viral 
reactivation from latency in sensory ganglia (23) 
1.4.4. Latent Viral Infection 
The most intriguing property of HSV infection is its ability to establish a latent infection 
in neurons of sensory ganglia.  Understanding the mechanisms that regulate the establishment 
and maintenance of latency as well as reactivation of virus from latency continues to be the most 
challenging problem in biomedical research.   
 
Axonal termini 
innervating the 
Neuronal cell bodies 
The three branches 
of the trigeminal 
Bundle of nerves 
containing axons
Figure 5: Graphic representation of the anatomy of the peripheral nervous system, where the 
eye may serve as the peripheral sight of infection. The eye is innervated heavily with axonal 
termini of the sensory neurons contained in the trigeminal ganglion.  The trigeminal ganglion is 
made up of three branches.  The inset shows the neuronal cell bodies present in the ophthalmic 
branch of the trigeminal ganglion. 
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After HSV-1 infection at a peripheral site (i.e. eye, mouth, etc.) the virus briefly replicates in the 
epithelial cells (where the productive infection follows the temporal pattern of gene expression 
described above) followed by retrograde axonal transport to the body of the neuronal cell in 
sensory ganglia that innervate the primary site of infection where it establishes latency for the 
life on the individual (Figure. 5). During stable latency the virus remains in a non-replicating 
episomal state. In humans and rabbits the virus can sporadically reactivate as result of poorly 
defined stimuli, such as immunosuppression, stress and exposure to UV-B irradiation (1,4).  
Upon reactivation the virus travels via the anterograde axonal transport and gains access to the 
primary site of the infection and cause recurrent herpatic disease.   
 Although there is a consensus that latently infected neurons harbor a functional viral 
genome but fail to produce virions, the definition of latency at the molecular level remains 
controversial.  Establishment of latency appears to be a rather promiscuous property of HSV.  
Recombinant viruses lacking essential proteins such as ICP4, ICP8 and TK are capable of 
establishing latency, but fail to reactivate (24,1). During latency the most abundant viral 
transcripts produced are the 2 and 1.5 kb latency-associated transcripts (LATs).  LATs are stable 
intronic RNA sequences that are anti-sense to ICP0 (25).  To date no viral proteins that are 
uniquely expressed during HSV-1 latency have been found given that, no LAT translation 
product has been discovered (4).  LAT-/- HSV-1, however, is capable of establishing a latent 
infection.  Recent studies have demonstrated anti apoptotic role of LATs; neurons that were 
infected with LAT deletion viruses were more susceptible to apoptosis in vivo and ex vivo 
(26,27), although the mechanism is yet to be defined.   
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  For many years it was believed that HSV latency represented a quiescent state in which 
transcription of the viral genome was limited to LATs. As LATs do not encode any proteins, 
expression of any lytic genes was considered reactivation from latency (28,25).  However, many 
recent studies, including ours, support a more dynamic view of latency, which suggests that 
limited viral gene expression continues in the absence of virion formation and viral DNA 
replication (29,30,31,32,33).  Low-level expression of α gene ICP4, and β gene TK were 
detected in vivo by nested RT-PCR (30) as well as in ex vivo latent TG cultures (32). In both 
studies, γ2 gene (gC) expression was not detected confirming the lack of viral reactivation.  A 
recent histological study of latently infected mouse TG revealed expression of transcripts for 
ICP4, TK, and in rare cases gC expression was also detected (29).   
 Therefore, the factors that contribute to the maintenance of HSV latency still remain 
poorly defined.   Evidence emerging from our laboratory (reviewed later) suggests the 
involvement of the immune system in regulating HSV-1 latency.   
1.4.5. Ocular Murine Model of Latency 
 
 In humans and rabbits, HSV-1 reactivates spontaneously and can be readily detected in 
teardrops of the eyes; however there are obvious disadvantages to studying viral latency in 
humans and rabbits.  The mouse model of latency has been the most widely used experimental 
system for investigating HSV latency and reactivation.  Just as in humans and rabbits, HSV-1 
corneal infection of the murine eye results in brief viral replication at the corneal epithelial cells 
followed by transport of the virus to the ophthalmic branch of the trigeminal ganglion where it 
briefly replicates and establishes a latent infection by 8 days PI (Figure. 6).  There are no known 
differences in the state of the latent viral genome in animals and humans.  The murine 
experimental system is particularly attractive because (i) spontaneous reactivation in mice is 
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 extremely rare and can be induced experimentally at a time of our choosing (34,35,36); (ii) 
availability of highly inbred, knockout and transgenic strains of mice is extremely valuable for 
investigating the role of the immune system in regulating viral latency and reactivation, and 
finally; (iii) the overabundance of available murine immunological reagents greatly exceeds any 
other animal experimental model.  Since MHC-H2kb restricted viral epitopes recognized by 
CD8+ T cells are defined, we used the C57BL/6 mice for majority of the studies presented here. 
               Mandibular Branch     Maxillary Branch 
Cornea 
Anterograde 
Retrograde 
Ophthalmic Branch
To CNS 
Sensory Neurons 
   
Figure 6: The murine experimental model of HSV-1 latency.  The cornea serves as the primary 
site of infection.  Once the virus gains access to axonal termini innervating the cornea it travels 
retrograde (blue) and establishes latency in the neuronal cell bodies in the ophthalmic branch of 
the TG.  Upon induced reactivation the virus emerges from latency and travels anterograde (red) 
and can cause herpetic disease at the primary site of the infection (cornea).  In very few cases 
the virus can access the central nervous system (CNS) and cause encephalitis.  Note that the TG 
is made up of three branches; mandibular, maxillary and ophthalmic.  The mandibular and 
maxillary branches contain neurons that innervate the mouth and the face.  
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 1.5. HSV Infections 
Documentation of herpetic diseases was first done as far back as in the Greek and Roman 
eras.  But it was not until the early 1900s when the true infectious nature of the virus was 
discovered (37). In the 1930s investigators were baffled by a paradoxical finding, only those 
individuals who had neutralizing antibodies to HSV were the ones who showed herpetic disease.  
In the next few decades advances in medicine resolved some of the anomalous observations and 
by the 1970s HSV was reclassified into HSV-1, which was found to cause infections “above the 
waist” and HSV-2, which primarily caused infections “below the waist”.   
 Infections caused by herpesviruses have become a considerable public health problem in 
the world.  There are eight known human herpesviruses that share many infectious properties and 
have many genetic similarities.  These include varicella-zoster virus (VZV), cytomegalovirus 
(CMV), Epstein-Barr virus (EBV), and human herpsesviruses 6, 7 and 8.  The two most related 
and genetically conserved herpesviruses are the HSV-1 and HSV2.  This thesis will focus mainly 
on HSV-1 with emphasis on the primary and memory immune responses to HSV-1 infection 
during latency.   
 
1.5.1. HSV Pathology and Pathogenesis 
 
HSV predominantly infects mucosal sites such as the eye, oropharyngeal areas, and 
genital areas.  HSV-1 is the primary cause of ocular and oropharyngeal infections and recent 
epidemiological data suggest that both HSV-1 and HSV-2 can cause genital herpes, although 
HSV-2 remains the major culprit (37,38).  Given that HSV is an especially cytopathic virus, the 
results of a productive infection at mucosal and mucocutaneous sites are clinically unpleasant.  
HSV infection induces painful skin lesions as a result of cellular death and inflammation; there is 
14 
 degradation of cellular plasma membrane leading to the formation of giant multinucleated cells, 
pustule and scabbing.  In rare instances HSV can infect the CNS, leading to death or permanent 
brain 
damage (39,40,37).  The pathology after a recurrent infection as a result of a reactivation is 
milder presumably because of an enhanced immune response.  HSV-1 infection of the eye leads 
to the destruction of corneal epithelium causing dendritic lesions.  The lesions can be detected by 
topical treatment of the eye with fluorescien.  The ocular dendritic lesions in the mouse cornea 
are strikingly similar to human corneal lesions (Figure 7)   
  
Figure 7: Dendritic lesions caused by HSV-1.  Topical treatment of fluoroscene on the eye 
reveals the dendritic lesions caused by HSV-1 infection of the eye as a result of epithelial cell 
damage.  Notice the similarities in the lesion caused by the virus in humans (left) and mouse 
(right). 
 
The virus forms a latent infection in the ophthalmic branch of the trigeminal ganglion. In 
humans, the virus sporadically reactivates and can reinfect the eye, a condition called recurrent 
herpetic disease that can lead to herpes stromal keratitis (HSK). Repeated infection of the eye 
can lead to permanent corneal damage and in some cases total loss of vision.   
 HSV is a remarkably successful pathogen because it can hide in post mitotic neuronal 
cells where antiviral drugs pose no danger.  Fortunately, HSV cannot survive out side living 
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 cells; therefore the virus can only spread through close contact with mucosal surfaces or abraded 
skin.  In most cases the virus spreads only to the ganglionic neurons that innervate the primary 
site of infection, but in special cases such as immuno-compromised and neonatal individuals, 
virus can spread to other branches of sensory ganglia, causing a disseminated infection (37,38). 
 
1.5.2. HSV Epidemiology 
 
There are many factors that contribute the spectrum of diseases caused by HSV such as 
age, geographical settings and socioeconomic status of individuals.  Studies with cadavers have 
shown that about 18% of people up to the age of 20 have latent HSV-1 in the TG, and virtually 
100% of cadavers aged 60 or older tested positive for latent HSV-1.    In the United States, at 
least 50% of the population is currently infected with HSV-1, however the rates are declining 
(38).  HSV-1 remains the leading cause of infectious blindness with at least 50,000 new or 
recurrent cases reported each year (40).  It is estimated that 8.4/100,000 new cases of ocular 
HSV occur each year and 149/10,000 ocular HSV cases are prevalent in the population of United 
States (38).  Ocular HSV infections include acute conjunctivitis, where 21% of all conjunctivitis 
cases in the US are caused by HSV infections.  About 20-25% of all HSV ocular infections lead 
to stromal keratitis.  In adults ocular HSV infection rarely leads to encephalitis or death, however 
in newborn and young children, ocular or oropharangeal HSV infection can be a cause of 
considerable morbidity and permanent brain impairment (38,37). 
 HSV-2 infections, which result in genital herpes, are also widespread.  Unlike HSV-1, 
incidence of HSV-2 infections is steadily rising in developed countries.  22% of adults in the US 
are HSV-2 seropositive, with incidence considerably higher in African Americans (~45%) than 
in Caucasians (17.6%).  Genital herpes is principally transmitted sexually in genital secretions, 
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 and contact with infected mucosal surfaces (37,38).  There are 500,000 new cases each year and 
prevalence of latent HSV-2 infection is estimated to be in the range of 40 to 60 million people in 
the US.   
 The high prevalence of HSV-1 and 2 infections in the world can be attributed to the 
chronic nature of the virus.  An individual can be infectious even though he/she may be 
asymptomatic; viral shedding occurs in almost all latently infected individuals.  Clinics have 
reported viral shedding in saliva, eye, and in genital areas in the absence of any herpetic lesion or 
disease, which makes preventing the transmission of HSV even harder.  
 Therefore, it is clear that HSV infections are increasing and becoming a menace to the 
public heath systems around the world.  The problem is expected to get worse because of the 
increasing number of individuals that are immunocompromised as a result of human 
immunodeficiency virus (HIV) infections, transplant patients and patients suffering form 
autoimmune disorders who are on immunosuppressive drugs.  Moreover, reactivation of HSV-1 
increases with age and since the life expectancy of population in developed countries continues 
to increase the problem of HSV mediated diseases will worsen.   
 Management of primary and recurrent HSV infections is limited to the use of antiviral 
drugs such as acyclovir and gancyclovir.  These drugs are effective only during productive 
infection, and are incapable of eliminating latent virus or preventing the virus from establishing 
latency (38,37,41).  All attempts to devise an effective vaccine have been largely unsuccessful. 
 
1.6. T Lymphocytes and Adaptive Immunity    
During an invasion of a pathogen, T lymphocytes are an invaluable weapon employed by 
our immune system to encumber the ensuing assault to the body.  There are two main classes of 
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 T lymphocytes; T helper cells (Th or CD4+ cells) that express the CD4 protein, and cytotoxic T 
lymphocytes (CTL or CD8+ cells) that express the CD8 coreceptor.   
CD4+ T cells recognize foreign antigens presented by antigen presenting cells (APC) in 
the context of major histocompatibilty complex II (MHC II) molecules.  CD4+ T cells are 
principally helper cells that are important in augmenting the function of CD8+ T cell mediated 
and humoral immunity, moreover recent studies have confirmed the importance of CD4+ T cells 
in maintaining CD8+ T cell memory (42-44) .  There are two types of Th cells: Th1 and Th2.  
Generation of Th1 cells requires the presence of interleukin 12 (IL-12), which is mainly secreted 
by dendritic cells (DC) and natural killer cells (NK cells).  Th1 cells are a major source of 
antiviral cytokines such as interferon γ (IFNγ) and tumor necrosis factor α (TNFα).  Th1 cells 
assist in the generation of an effective cell mediated immunity by secreting growth factors such 
as IL-2, that are necessary for clonal expansion of CD8+ T cells as well as enhancing the 
cytotoxic functions of CD8+ T cells.  CD4+ T cells can activate DCs by providing costimulation 
by way of CD40-CD40 ligand (CD40L) interaction; this “licensing” makes DCs better antigen 
presenting cells for T lymphocytes (45).   Th2 cells are generated in response to IL-4 secreted by 
DCs.  Th2 cells activate B cells by secreting cytokines such as IL-4 and IL-5, as well as 
providing the CD40L to stimulate the CD40-CD40L pathway.  IL-4 and CD40-CD40L 
interaction between B cells and Th2 cells is extremely important in inducing isotype switching 
and clonal expansion of B cells, which, leads to the differentiation of B cells into plasma cells. 
Plasma cells produce copious amounts of antibodies to combat extracellular pathogens.  Many 
studies have demonstrated the importance of CD4 T cell responses in immunity to HSV 
infections (46,47,48) but for the sake of relevance and brevity this thesis will concentrate 
primarily on CD8+ T cells.   
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 1.6.1. Antigen Recognition and Processing 
 
Major Histocompatibility Complex Class I:   
Intracellular pathogens such as viruses and some bacteria, once inside a cell, remain 
hidden from the innate and humoral immune responses; therefore our body has evolved to devise 
a very efficient system of alerting CD8+ T cells to the presence of intracellular pathogens.  MHC 
class I molecules are expressed on virtually all cell types including neurons.  MHC I molecules 
are made up of a 43-kDa heavy chain (α), and a 12-kDa light chain (β).  The heavy chain 
consists of three immunoglobulin like domains: α1, α2 and α3, which non-covalently associate  
peptide
α3 
α2α1 
β2m
Figure 8: A structural schematic of the MHC I molecule. The heavy chain contains the three α 
domains and spans the plasma membrane.  β2m is the light chain and associates extensively with 
the three domains of the heavy chain.  The peptide binds in the groove contained with in the α1 
and α2 domains.   
 
with the light chain β2-microglobulin (β2m). The α3 domain spans the plasma membrane and 
has a binding site for the CD8 coreceptor (Figure 8).  The heavy chain amino terminal domains 
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 α1 and α2 form the peptide-binding groove, which accommodates peptides 8-9 residues in 
length (49).    
Antigen Processing and Presentation:  
 MHC class I antigen processing and presentation (outlined in Figure 9) constitutes a 
complex series of events that lead to the presentation of foreign and endogenous peptides in the 
context of MHC I molecules to T cell receptors (TCRs).  MHC class I light chains are 
synthesized in the endoplasmic reticulum (ER) where they remain in a partially folded state 
bound to chaperone protein calnexin (50). β2m binds to the α light chain further stabilizing the 
complex.  Other chaperone proteins such as calreticulin and tapasin bind to the α-β2m complex 
bringing it in close proximity to the TAP subunits.   Viral and other cytoplasmic proteins are 
processed and  
proteasome
viral 
protein 
TAP
tapasin
calreticulin calnexin
Figure 9: MHC class I antigen presentation pathway.  Steps in the antigen processing and 
presentation pathway are outlined in the text.    
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 degraded into small peptides by the action of several processing enzymes and proteosomes.  
Small 8-10mer peptides are transported inside the ER by the ATP dependent TAP transporters 
where they associate with the empty MHC I complexes.  The properly folded MHC-peptide 
complexes are transported to the surface of the cell by the Golgi transport system (49,50).  
Extracellular proteins can also be taken up by antigen presenting cells and shuttled into the 
endogenous MHC class I pathway of antigen presentation, a process that is referred to as cross 
priming (51). Cross priming is particularly important in eliminating highly cytopathic viruses 
that can cause extensive cellular necrosis, thus releasing viral proteins into the extracellular space 
(52).   
S   S
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Figure 10: T Cell Receptor Complex.  The TCR and accessory molecules involved in 
intracellular signaling are shown.  The CD8 coreceptor is a homodimer that binds to invariant 
chain of the MHC molecule stabilizing the TCR MHC-peptide interactions. 
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 T Cell Receptors:  
 Adaptive immune response to intracellular infectious agents is initiated by the 
recognition of antigen by T cell receptors expressed on CD8+ and CD4+ cells.  The structure of 
the TCR (Figure10) is similar to the antigen-binding portion of an antibody molecule.   The TCR 
is comprised of an α and a β chain, which are linked by a disulfide bond.  Each chain consists of 
variable (Vα and Vβ) as well as constant (Cα and Cβ) regions.  The membrane proximal 
constant regions have cytoplasmic extensions called the hinge regions that contain the disulfide 
bonds linking the two chains together.  The variable regions of the α and β domains form the 
complementarity-determining regions (CDRs).  These hypervariable regions confer to the TCR 
an astonishing ability to recognize numerous different antigens.  There are three CDR loops that 
form the MHC-peptide binding sites on the TCR α and β variable regions. The CDR3 loop is a 
highly hypervariable region that contributes the most to the binding of peptide, while the CDR1 
and CDR2 loops interact predominantly with the MHC (50,53).  After the T cell recognizes the 
antigen being presented by MHC the TCRs on the surface of the T cells cluster together along 
with other adhesion molecules to form an organized complex between the antigen-presenting cell 
forming an immunological synapse (54).  The central region of the organized synapse is called 
the supramolecular activation cluster or cSMAC, which contains the TCRs as well as 
costimulatory molecules (55).  Astonishingly, even if a single TCR engages with a peptide-MHC 
molecule the events that lead to the formation of the cSMAC of T cells are initiated (56).  The 
functional activation of T cells is carried out by intracellular signaling molecules and accessory 
proteins in the CD3 complex that include the δ, γ and ζ chains.  The proteins of the CD3 
complex contain immunoreceptor tyrosine-based activation motifs (ITAMs), which when 
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 phosphorylated induce a cascade of signaling events leading to the expression of certain genes 
like c-fos, c-jun and NFκB activating the T cells to become effector cells (57).   
1.6.2. CD8+ T Cells 
 
Effector Mechanisms:  
 CD8+ T cells are an important arsenal in the fight against viral and bacterial infections.  
Recent advances in technology such as MHC tetramers, intracellular cytokine staining as well as 
improvement in imaging have underscored the important role(s) CD8+ T cells play in 
immunosurveillance and subsequent eradication or control of viruses, bacteria and tumors 
(58,59).  The two main effector mechanisms employed by CD8+ T cells are: (a) perforin/granule 
and Fas mediated destruction of infected cells and (b)  secretion of antiviral cytokines (60).   
Cytolytic mechanisms of CD8+ T cells: 
 There are two major pathways by which CD8+ T cells kill their target cells; 
perforin/granule release and Fas-FasL.  Several studies have shown the importance of 
perforin/granzyme mediated killing in eliminating or controlling viral infections (61-64). 
However, in some infection models lack of perforin did not hinder the adequate clearance of the 
pathogen (65).  CTLs harbor lytic granules in their cytoplasm that store perforin and other 
proteases called granzymes.  Granzyme A (GrA) and GrB are the most important molecules that 
are critical in inducing apoptosis in target cells.  GrB is a potent apoptotic protease and can 
induce death in a target cell within a few minutes (66). However, GrA is less potent and can 
cause delayed apoptosis of virally infected cells (67,68,69,70). After a CTL interacts with an 
infected target cell the TCRs polarize towards the interface with the target cell forming an 
immunological synapse.  Upon CTL activation the granules also polarize towards the target cell 
and are released within the synapse in an organized secretory domain (71,72).   
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  The other mechanism by which CTLs cause target cell apoptosis is by the interaction of 
FasL with Fas expressing target cells.  This interaction initiates a cascade of signaling events 
mediated by fas-associating protein with a death domain (FADD) that can lead to caspase 
activation and eventually the death of the target cell.  This pathway, however, is more 
promiscuous and considerably slower than perforin mediated apoptosis (65,60). 
Noncytolytic mechanisms: 
 In the tug of war for survival between the virus and its host, recent studies have 
demonstrated that noncytolytic mechanisms utilized by lymphocytes and other cells of the 
immune system are critical in order to tip the balance in favor of the host (32,73,74).   
 Cytokines secreted by myriad of cell types during innate as well as adaptive immune 
responses play a pivotal role in controlling or eliminating viral infections. 
CD8+ T cells primarily secrete interferon γ (IFNγ), tumor necrosis factor α (TNFα) and 
interleukin 2 (IL-2).  IFNγ and TNFα have direct and indirect antiviral activities. IFNγ can 
positively regulate antigen processing and presentation by augmenting proteasome function and 
MHC gene expression.  Apart from having direct aniviral activities both cytokines have many 
immunoregulatory functions by which they activate other immune cells such as NK cells, 
macrophages and T cells to become better effector cells.  They can also enhance the production 
of chemokines and other cytokines.  IFNγ is critical in skewing the immune response to a Th1 
phenotype, which is necessary to combat intracellular pathogens (75,60,76). 
1.6.3. CD8+ T cell Memory 
 
 Formation of immunological memory is the inimitable feature of the adaptive immune 
response and is simply defined as a more efficient and vigorous immune response upon re-
exposure to the same antigen.  Despite recent progress, the mechanisms underlying the 
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 formation, maintenance and impairment of T cell memory remain poorly understood.  
Unresolved issues relevant to T cell memory include: (a) the role of antigen, especially in 
persistent viral infections in memory formation and maintenance; (b) what are the factors that 
contribute to tissue-specific homing and retention of effector/memory cells; and (c) the 
mechanisms responsible for homeostasis of memory T cell pools in lymphoid and nonlymphoid 
tissues.   
 After a viral infection the CD8+ T cell immune response in lymphoid organs follows a 
pattern characterized by: (i) initiation of the immune response; (ii) clonal expansion of viral 
specific CD8+ T cells; (iii) a substantial reduction of effector CD8+ T cells and finally; (iv) 
formation of a stable memory pool (77-80).   There is a substantial increase in lymphoid antigen 
specific CD8+ T cells during the expansion phase of an antiviral immune response. Seven days 
after lymphocytic choriomeningitis virus (LCMV), infection viral specific CD8+ T cells account 
for more than 80% of all CD8+ T cells present in the draining lymph nodes (78).  Thirty days 
after LCMV infection the magnitude of memory CD8+ T cell pool that formed depended on the 
initial burst size of CD8+ T cell clonal expansion.  Recent studies have shown that in response to 
a viral infection, memory T cells can be found in lymphoid organs as well as in the peripheral 
non-lymphoid tissues where they may reside permanently or recirculate throughout the body. A 
surprising observation made from these studies was that the trafficking of antigen specific 
effector T cells to non-lymphoid tissues was not antigen dependent.  These findings challenge 
the existing concept that activated T cells only migrate to primary sites of infection and reside 
mainly in the lymphoid organs (81,82,83).  However, the capacity of the CD8+ T cells retained in 
non-lymphoid tissues to protect upon secondary challenge with pathogen is yet to be determined.  
These and other findings (84) have provided the basis for a premise that memory T cells can be 
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 subdivided based on their function, anatomical location as well as surface expression of 
chemokine receptors and cell adhesion molecules.  The “effector memory” cells primarily 
migrate to and reside in non-lymphoid tissues.  Functionally these cells produce IFNγ and are 
cytotoxic directly ex-vivo even months after infection (81).  Phenotypically, effector memory 
cells are CCR7lo, CD62lo, CD44hi (84,85).  “Central memory” cells are both phenotypically and 
functionally distinct from effector memory cells; they are largely retained in lymphoid organs, 
and produce copious amounts of IL-2 but little IFNγ.   Lymphoid memory cells lack granzyme B 
expression and, therefore, do not retain direct ex vivo cytotoxic activity (84,77,81).  However, in 
persistent infections the concept of the existence of mutually exclusive central and effector 
memory T cells may be an over simplification (86). 
 Recent studies have clarified mechanisms that regulate formation and maintenance of 
memory but many questions remain unanswered. The majority of the models used to study 
memory utilize non-cytopathic viral infections that are readily cleared from body.  However, our 
understanding of T cell memory in persistent and latent viral infections remains at a rudimentary 
level.  In mice, LCMV specific memory CD8+ T cells can survive without antigen persistence or 
interaction with cognate MHC molecules (87). This suggests that maintenance of memory T cells 
is antigen independent. However, some investigators argue that mere survival of memory T cells 
does not connote their functionality.  These investigators make a distinction between memory, 
and “functional” memory.  They postulate that efficient functional T cell memory is maintained 
only when low-level antigen persists in the body (88,89).  This concept is supported by clinical 
data obtained from HIV patients that suggest a direct correlation between viral loads and the size 
of the memory T cell pool in the blood.  A recent study showed that memory CD4+ T cells can 
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 be maintained in presence or absence of MHC interaction; however, the former were functionally 
defective (90).   
 Members of cytokine family that use the common cytokine receptor γ chain (γc) are 
extremely important in mediating the progress of CD8+ T cell responses to pathogens.  Of 
particular interest are IL-2, IL-15 and IL-7.  IL-2R and IL-15R use the same β chain but unique 
α chains.  All three cytokines use the common γ chain.  There is evidence of differential 
expression of cytokine receptors during an anti-viral immune response; naïve T cells express IL-
7Rα, IL-15Rα, and IL-2Rβ, but not IL-2Rα.  Memory CD8+ T cells express the β chain of the 
IL-2/IL-15R as well as IL-7Rα (91-93).  Thus, it appears each cytokine may have a distinct 
function at different stages of a CD8+ T cell response to viral infections.  Several recent studies 
have suggested that IL-2 and IL-15 have contrasting roles in CD8+ T cell memory formation and 
maintenance (94,95, 96, 97).  There is conflicting data on the role of IL-2 at different phases of 
the CD8+ T cell immune response.  In vitro data indicate that IL-2 exposed CD8+ T cells become 
efficient effector memory T cells that migrate primarily to the non-lymphoid organs, while IL-15 
exposed CD8+ T cells become central memory cells (98). Adoptive transfer experiments with IL-
2-/- and IL-2R-/- CD8 T cells have shown the importance of IL-2 in the sustained expansion of 
CD8+ T cells during the acute phase of VSV infection (97,99).  There is considerable evidence 
that IL-15 is very important in the maintenance and formation of an adequate memory CD8+ T 
cell pool (100,101,102,103).  IL-15 is not only important in homeostatic proliferation of memory 
CD44hi CD8+ T cells but also in survival of memory cells by inducing anti-apoptotic molecules 
such as BCL-2 and BCL-X (104). In spite of these recent advances, the role of IL-2 and IL-15 in 
modulating CD8+ T cell responses to persistent or latent viral infection is not defined. Whether 
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 or not the generation and maintenance of extra-lymphoid memory CD8+ T cell population 
requires IL-15 and/or IL-2 has yet to be delineated.   
1.7. Immune Responses to HSV-1 Infection 
 The nature of the immune response at primary sites (such as skin and cornea) and 
lymphoid organs during acute HSV-1 infection has been extensively investigated, yet little is 
known about the immunological events that occur in sensory ganglia (the site of latent infection).  
After HSV-1 infection the immune response in the cornea is characterized by a complex series of 
events.  Although the cornea is considered an immune privilege site, HSV-1 infection in mice 
leads to an elevated leukocyte infiltration dominated by polymorphonuclear leukocytes (PMN), 
followed largely by CD4+ T cells, which mediate the continued infiltration of PMNs by secreting 
Th1 cytokines IFNγ and IL-2.  CD4+ T cell mediated inflammation leads to severe corneal 
scarring and loss of vision by 21 days post infection (105-109,110,111).  For the sake of 
relevance and brevity the subsequent discussion will primarily deal with acute and latent immune 
responses in lymphoid organs and the TG after HSV-1 corneal infection.   
1.7.1. Immune Response to Acute HSV-1 Infection 
 
 Unlike LCMV and VSV, HSV infection does not represent a systemic, but rather a 
localized infection.  Since HSV is notorious for its ability to block the MHC-I antigen processing 
pathway, it was believed that CD4+ T cells alone were critical in clearing primary HSV infection 
in humans and in mice (112,113,114,115).  However recent human studies by Lawrence Corey 
have demonstrated that CD8+ T cells are equally important in clearance of HSV-1 from primary 
sites of infection (116-119).   
 A number of studies using a murine model of HSV-1 corneal and cutaneous infection 
have established the importance of T lymphocytes during acute infection (46,120).  The immune 
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 response to HSV-1 in the draining lymph nodes is characterized by a relatively meek CD8+ T 
cell activation.  5 days after a cutaneous HSV infection, 5% of the lymphoid CD8+ T cells are 
HSV specific, of those 90% recognize an epitope contained in the γ1 gene product gB (gB498-505) 
and a smaller fraction recognize an epitope contained in early protein, ribonucleotide reductase 
(RR1822-829) (121-123,124).  The TCR usage of gB specific CD8+ T cells is dominated by Vβ10 
and a subdominant Vβ8 elements (125).  Since HSV-1 causes a localized infection it does not 
infect the draining lymph nodes but studies with foot pad infection show a rapid transport of viral 
antigens presumably by langerhan cells and dendritic cells to the draining lymph nodes.  gB 
specific CD8+ T cells were activated with in hours of infection indicating rapid processing and 
presentation of gB epitope from the primary sites of infection to the LN by APCs (126,127). 
Furthermore, using fibroblasts as targets and gB specific CD8+ T cells, Mueller et.al. 
demonstrated the rapid rate by which gB can be presented to activate CD8+ T cells (128).    
 After corneal or foot pad infection HSV-1 is transported to the sensory ganglia within 24 
hours, where it briefly replicates and establishes latency in neurons by 8 days PI.  Histological 
studies indicate the initial leukocyte infiltrate in the TG includes macrophages, NK cells and γδ 
T cells, followed by CD8+ and CD4+ T cells, just before replicating virus is cleared (5-7 days PI) 
(129).   Macrophages and γδ T cells are the dominant leukocytic population during the lytic 
phase of the infection (3-7 Days PI), and control early HSV-1 replication in the TG.  Depletion 
of γδ T cells lead to a decrease in IFNγ as well as a dramatic increase in HSV-1 titers in the TG 
(130).  Macrophage depletion significantly reduced the expression of IL-12, iNOS and TNFα, 
which resulted in increased HSV-1 replication and spread in the ophthalmic branch of the TG 
(131).  Although depletion of γδ T cells or macrophage did not lead to an increase in duration of 
HSV-1 replication or affect its ability to establish latency , CD8+ and αβ+ T cell depletion 
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 significantly augmented HSV-1 neurovirulence resulting in lethal viral encephalitis 
(131,130,132).  The mechanisms by which CD8+ T cells provide protection from encephalitis are 
not well understood.  A study by Simmons’ group demonstrated the importance of GrA in 
preventing viral spread in the TG during acute HSV-1 infection (133) suggesting a role of the 
cytolytic machinery.   Other antiviral cytokines may also play a crucial role in preventing viral 
spread into the CNS. 
1.7.2. Immune Response to Latent HSV-1 Infection 
 
 There is evidence for a constant host immune surveillance in latently infected TG.  
Extensive histological analysis by our laboratory of mouse TG after HSV-1 corneal infection 
revealed that CD8+ T cells continued to accumulate until 14 days PI which is long after the 
establishment of latency.  The CD8+ T cells were predominantly in close apposition to the 
neuron cell bodies.  These cells seemingly remained in the ganglion beyond 90 days PI (129).  
Support for the role of the immune system during latency was further strengthened by studies 
that demonstrated persistent cytokine and chemokine production in latently infected murine TGs.   
Expression of chemokines that are essential for attracting T cells such as regulated on activation, 
normal T cell expressed and secreted (RANTES), and T cell-derived cytokines (i.e. IFNγ and 
TNFα) can be readily detected in latently infected TGs as far beyond as 90 days PI 
(129,134,135,136,22).   
 
2. STATEMENT OF THE PROBLEM 
 
 HSV infections around the world are increasing, providing a formidable challenge for 
public health systems.  Apart from alarming rise in the incidence of herpetic disease because of 
immunosuppression and sexual transmission, herpes stromal keratitis continues to be a leading 
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 cause of blindness by an infectious agent (38,137).  Understanding the mechanisms involved in 
latency and reactivation has been a goal of many researchers for over half a century, but progress 
has been slow.  Until recently, the role of the immune system in controlling HSV-1 latency was 
largely ignored due to the prevalent concept that HSV-1 latent infection in sensory ganglia 
represents a quiescent state wherein a lack of viral gene and MHC-I expression conceals the 
virus from the host immune system.  As outlined in the previous section, findings in our and 
other laboratories challenge this concept.  In addition, work by Simmons’ group has clearly 
confirmed the expression of MHC-I molecules on neurons by histological and cytometric 
analysis (138,139).  Eradicating latent HSV-1 from sensory neurons is not currently feasible and 
current vaccine strategies have been unsuccessful in preventing complete establishment of 
latency (140,141,142).  Recent findings implicating the possible role of the host immune system 
during latent infection provide promise for immunologic approaches to intervention in recurrent 
herpetic disease.  Therefore, the purpose of this study was to completely understand the adaptive 
immune response that occurs at the site of the latent infection, and to test the hypothesis that 
CD8+ T cells are intricately involved in regulating viral latency and gene expression, with the 
goal of facilitating better vaccination strategies to combat herpetic infections.  To this end we 
have attempted to dissect the CD8+ T cell immune response in the TG during acute and latent 
infection by determining the antigenic specificity and their phenotypic and functional properties.  
We have investigated the ability of CD8+ T cell subsets to prevent reactivation and regulate viral 
gene expression, as well as the CTL mechanisms essential for maintaining latency.  We have 
also characterized the mechanisms that govern the retention of HSV-specific memory/effector 
CD8+ T cells in latently infected TG. 
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 3. MATERIALS AND METHODS 
 
The contents of section 3 has been modified from articles (32,33,73).  Copyright permission is on 
file with Kamal Khanna. 
 
3.1. HSV-1 Infection 
6–8-wk-old female C57BL/6, perforin KO (C57BL/6JPfp<tm15dz) (Jackson Laboratory, 
Bar Harbor, ME), BALB/C (Frederick Cancer Research Center, Frederick, MD), and IL-15 KO 
(Taconic Farms, Germantown, NY) mice were anesthetized by intramuscular injection of 2.0 mg 
of ketamine hydrochloride and 0.04 mg of xylazine (Pheonix Scientific; St Joseph, MO) in 0.2 
ml of HBSS (Biowhittaker, Walkersville, MD).  The RE strain of HSV-1 used in these studies 
was grown in Vero cells, and intact virions were purified on Percoll (Pharmacia LKB 
Biotechnology, Inc.Piscataway, NJ) gradients.  Corneas of anesthetized mice were scarified 10 
times in a crisscross fashion with a sterile 30- gauge needle, and the eyes were infected topically 
with 3 µl of RPMI (Biowhittaker) containing 105 PFU of HSV-1.  
 
3.2. Single cell suspensions of TG 
At various times after HSV-1 corneal infection, mice were perfused with PBS, and TGs 
were excised and treated with collagenase type I (800 units/ml; Sigma Chemical Co., St Louis, 
MO) for 1.5 h at 37°C.  The TGs were dissociated into single cell suspension by trituration with 
a P200 pipet. 
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 3.3. Reagents 
 Peptides gB498-505 (SSIEFARL) and RR1822-829 (QTFDFGRL) were purchased from 
Research Genetics (Invitrogen Corporation, Carlsbad, California).  Peptide purity was confirmed 
to be > 95% by reverse phase HPLC analysis.  Phycoerythrin (PE)-conjugated H-2Kb tetramers 
complexed with gB498-505 or RR1822-829 were generated by the NIAID Tetramer Core Facility 
(Emory University Vaccine Center, Atlanta, GA).  
 PE-conjugated and purified H-2Kb:Ig dimer, PE-conjugated anti CD8α (clone 53-6.7); 
fluorescein isothiocyanate-conjugated anti CD44 (IM7), anti CD69 (H1.2F3), and anti IFNγ 
(XMG1.2); and Cy-Chrome™-conjugated anti CD45 (30-F11), were purchased from BD 
Pharmingen, San Diego, CA.  Isotype control antibodies were purchased from BD Pharmingen; 
Caltag, Burlingame, CA; and Jackson ImmunoResearch (West Grove, PA). 
 
3.4. Immunohistochemistry 
 Following perfusion with 1 X PBS, mice were sacrificed and TG were excised from 
latently infected mice and processed for frozen sectioning or whole organ staining.  For frozen 
sectioning the TG were embedded in optimal cryogenic temperature (OCT) and immediately 
frozen in liquid nitrogen, and 10 µm serial sections were cut using a microtone apparatus at -
20°C.  Frozen TG sections were incubated with rat anti mouse CD8α (53-6.7, 1µg/ml, 
Pharmingen) overnight at 4°C.  The sections were then washed 3 times with 1 X PBS for 5 min 
each, fixed with 2% paraformaldehyde for 30 min at 4°C, followed by the addition of Alexa 
Fluor® 546 goat anti rat IgG (2 µg/ml, Molecular Probes, Eugene,OR) diluted in 2% normal goat 
serum and PBS.  The sections were incubated at 4°C for 3 h, washed, mounted with Immu-
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 Mount, Thermo Shandon, Pittsburgh, PA, and analyzed using a Bio-Rad 2000 confocal 
microscope (Bio-Rad, Richmond, VA) 
 Alternatively, whole TGs were stained using a modification of a previously described in 
situ tetramer staining procedure (143,144).  Briefly, excised TG were washed in PBS and 
incubated overnight at 4°C in  round bottom 96-well plates with PE conjugated MHC class I 
tetramers (2µg/ml) and rat anti mouse CD8α (53-6.7, 1µg/ml, Pharmingen) diluted in 2% normal 
goat serum and PBS.  Next day tissues were washed 5 times for 15 min each with 1 X PBS, and 
fixed with 2% paraformaldehyde for 30 min at 4°C, and incubated overnight at 4°C with Alexa 
Fluor® 546 goat anti rat IgG (2 µg/ml, Molecular Probes) and rabbit anti-PE (1µg/ml, Biomeda, 
Hayword, CA) diluted in 2% normal goat serum and PBS.  The tissues were then washed as 
described above and incubated for 6 h at 4°C with Alexa Fluor® 488 goat anti rabbit IgG (2 
µg/ml, Molecular Probes).  The tissues were washed similarly and mounted on slides using 
Immu-Mount.  The stained whole mount tissues were analyzed by confocal microscopy.  The 
image acquisition was done using Bio-Rad Laser Sharp® and image analysis was performed 
using Metamorph® software (Universal Imaging Corp, Downingtown, PA).   
 
3.5. Flow Cytometry 
 Single cell suspensions of TG were pooled and passed through a 40-micron filter.  
Aliquots of TG cells (2 TG equivalents) were added to 5 ml polystyrene round bottom tubes 
(Becton Dickinson, Franklin Lakes, NJ).  FC receptors on the cells were blocked by incubating 
the single cell suspension with anti-FC antibody for 15 min at 4°C and stained for the cell 
surface markers (0.5µg/ml) for 30 min at 4°C.  The cells were then washed twice and fixed in 1% 
paraformaldehyde (PFA, Electron Microscopy Sciences, Fort Washington, PA) and stored at 4°C 
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 until analyzed.  The cells were acquired on a FACSCalibur or LSR II (Becton Dickinson) and 
analyzed using WinMDI data analysis software (J. Totter, The Scripps Clinic, La Jolla, CA).  
Single cell suspensions of TG were first stained with the anti CD8α antibody for 30 min. at 4°C 
followed by gB498-505 or RR1822-829 tetramers for 20 min. at room temperature.  Cells were fixed 
with 1% PFA, and analyzed immediately by flow cytometry.  
 
 
 
3.6. Intracellular IFNγ detection 
 
 Intracellular IFNγ stains were carried out using Cytofix/Cytoperm kit with 
Golgiplug™ (BD Pharmingen) in accordance with the manufacturer’s instructions.  Briefly, 
aliquots of pooled TG cells (2 TG equivalents) were incubated with 1 x 106 stimulator cells and 
Golgiplug™ for 6 hours at 37°C in flow tubes.  Stimulator cells were the B6WT3 fibroblast cell 
line that were uninfected, infected with HSV-1 at an MOI of 5 for 6 hours, transfected to produce 
the gB498-505 peptide (B6/T-350gB) (145), or transfected to produce the RR1822-829 peptide (B6/T-
350RR1) (123). After the 6 hrs incubation, the cells were stained for cell surface molecules and 
intracellular cytokines.  Fc receptors were blocked by incubating the TG single cell suspension 
with 1µg FC block™ (BD Pharmingen) for 15 min at 4°C.  The cells were then washed twice 
with flow wash buffer (1% FCS, 0.1% NaN3 in 1XPBS) and stained with fluorochrome-
conjugated antibody for the cell surface proteins CD45, and CD8α for 30 min at 4°C.  The cells 
were washed twice with flow wash buffer and resuspended in Cytofix/Cytoperm™ solution for 
20 min at 4°C to fix and permeabilize. The cells were washed twice with 1X Perm/Wash™ 
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 buffer followed by incubation with 0.5µg/stain of flourochrome-conjugated anti-IFNγ diluted in 
1X Perm/Wash™ buffer for 30 min at 4°C.  The cells were washed twice with 1X Perm/Wash™ 
buffer followed immediately by flow cytometric analysis.  
3.7. Preparation of TG cultures  
3.7.1. TG cultures supplemented with gB-specific CD8+ T cell clone 
 
Single cell suspensions of pooled TGs were added to each well (1/2 TG/well) of a 48-
well tissue culture plate, and the cells were cultured with DMEM (Biowittaker) containing 10% 
FCS (HyClone, Logan, UT), and 10 U/ml recombinant murine IL-2 (R&D Systems, Inc., 
Minneapolis, MN).  Where indicated, the TG cells were depleted of CD8+ T cells by 
immunomagnetic separation using anti-CD8-coated dynabeads® (Dynal ASA, Oslo, Norway).   
Fibroblasts 
Neurons 
T cells 
Figure 11: Schematic of a TG culture.  4 days after culture initiation a monolayer of fibroblasts 
forms (grey cells) and neurons (green) and T cells (red) can be found on top of the monolayer of 
fibroblasts.  After a viral reactivation event, plaques can be observed when fibroblasts around 
the reactivation foci are destroyed forming an area of cellular clearance. 
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 Single cell suspension of pooled TGs were treated with anti-CD8α MAb-coated magnetic 
beads for 30 min at 4°C followed by seven rounds of magnetic separation using a high power 
magnet.  The efficiency of CD8+ T cell depletion was routinely greater than 98% as determined 
by flow cytometry.  The CD8+ T cell clone (2D5) specific for the HSV-1 gB498-505 epitope was 
maintained as previously described (146).  Briefly, 2D5 cells were maintained in complete 
Iscove’s Modified Dulbecco’s Medium (IMDM) (Biowhittaker) containing 10% FCS (HyClone) 
and 5x10-5 Molar beta-2-mercaptoethanol (β2-ME).  Complete IMDM was further supplemented 
with 10% rat T-cell-Stim (Becton Dickinson).  The 2D5 cells were maintained by 3 day 
stimulation and 3 day rest cycle, B6/T-350gB fibroblast cells were used as stimlators.  For TG 
cultures 2D5 cells used after a 3-day rest period in which no stimulant was added.  On the day of 
the experiment the 2D5 cells were removed from the wells using versene, washed and added to 
the TG cultures at various doses.  Naïve CD8+ T cells were obtained from the spleens of 
uninfected mice by magnetic activated cell sorting (MACS®, Miltenyi Biotec, Auburn, CA) 
according to the manufacturer’s instructions.  The naïve CD8+ T cells were washed and added to 
the TG cultures. 
3.7.2. TG cultures to determine IFNγ mediated protection 
At 35 days after HSV-1 corneal infection, the ipsilateral TG was excised and treated with 
collagenase type 1 (800 U/ml; Sigma, St. Louis, Mo.) for 1.5 h at 37C and dispersed into single 
cells by triturating as previously described (32). The cells from multiple TG were pooled, and the 
neurons were counted. The equivalent number of cells from one TG (approximately 10,000 
neurons) was added to each well of a 24-well tissue culture plate (catalog. no. 353047; Falcon), 
and the cells were incubated in culture medium consisting of Dulbecco's modified Eagle's 
medium, 10% fetal calf serum (HyClone, Logan, Utah), and recombinant murine IL-2 (10 U/ml; 
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 R & D Systems, Inc., Minneapolis, Minn.). Some cultures received ACV (50 µg/ml; Glaxo 
Wellcome, Inc., Research Triangle Park, N.C.) during the first 4 days of incubation. This 
treatment was shown to be optimal in preliminary experiments. After 4 days, the ACV-
containing medium was removed and the cultures were rinsed with culture medium twice, and 
then they were incubated for an additional 10 days in culture medium alone or culture medium 
supplemented with monoclonal antibody (mAb) to IFNγ (20 µg/ml, clone R4-6A2) or CD8α 
(100 pg/ml, clone 2.43) or with mouse recombinant IFNγ (rIFNγ) (1,000 World Health 
Organization units/ml; R & D Systems, Inc.). Where indicated, TG cell suspensions were 
depleted of CD8+ T cells or CD45+ cells by treatment with anti CD8α MAb or anti-CD45 MAb-
coated magnetic beads (6 beads/cell, Dyna- beads; Dynal) followed by seven rounds of magnetic 
separation. The resulting TG cell suspensions contained less than 1% of the depleted cell 
population as assessed by immunofluorescent staining with PE-conjugated anti-CD8α mMb 
(clone 53-6.7; PharMingen) or biotinylated anti-CD45 mAb (clone m1/9.3.4.HL2) and FITC-
conjugated streptavidin followed by flow cytometric analysis. Some neurons and supporting cells 
were lost from the TG cell suspensions during immunomagnetic depletion, but adjustments were 
made so that the depleted and nondepleted TG cultures contained comparable numbers of 
neurons. Preliminary studies established that mock depletion with uncoated beads did not 
influence assay results, so this control was not included in the studies described herein.  
 
3.8. IFNγ titration in TG cultures 
At various times after culture initiation 50µl of medium were removed from each culture 
and tested for IFNγ content using a standard-enzyme linked immunosorbent assay (ELISA).  
Plates were coated with coating buffer (0.1M Na2HPO4; dissolve 1.42 gram of sodium phosphate 
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 (Sigma) into 80 ml H2O, pH 9.0) containing anti-IFNγ antibody (clone R4-6A2) at 2 µg/ml and 
kept overnight at 4°C.  The next day plates are washed 0.05%Tween-20/PBS four times and 
blocked with 1%BSA/PBS for 1hr at room temperature.  The plates are washed as before and the 
diluted samples are added in duplicates into each well and incubated for 2 hr at room 
temperature.  The supernatant was decanted and plates were washed 6 times before the addition 
of biotin-conjugated anti-IFNγ detection antibody (R&D; 1µg/ml) for 1hr at room temperature.  
The plates were washed 6 times and incubated with Avidin-horseradish peroxidase (Pharmingen, 
SA-HRP; 1:1000) for 30 min at room temperature. The plates were again washed 8 times and the 
TMB developing solution was added to each well and allowed to stand for 15 min at room 
temperature, the reaction was stopped by the addition of 100µl per well of 1N H2SO4.  The 
optical density of the wells was detected by a standard ELISA plate reader.  The concentration of 
the protein was measured by comparing OD readings to the standard curve generated by serial 
dilution of recombinant IFNγ standards. The sensitivity of the assay was 15.6 pg/ml. 
 
3.9. Monitoring of TG cultures for HSV-1 reactivation from latency 
Within 3 days of TG culture initiation, the neurons could be observed on a monolayer of 
fibroblast-like cells.  The cultures were monitored using three criteria to define HSV-1 
reactivation from latency.  A culture was considered positive for HSV-1 reactivation if 
microscopic examination revealed the presence of viral cytopathic effects (CPE), or if infectious 
virus was detected in serial samples of culture supernatant (50µl/culture) using a standard viral 
plaque assay on monolayers of Vero cells.  After each sampling, the medium was replaced with 
an equal volume of fresh medium of the same composition (32).  To further confirm monitoring 
accuracy, selected cultures that were negative for reactivation based on the above criteria were 
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 tested for the presence of HSV-1 γ2 gene (glycoprotein H) transcripts by RT-PCR.  Cultures that 
lacked viral cytopathic effect and infectious virus were uniformly negative for gH transcripts.   
 
3.10. Reverse transcription PCR   
Ten days after initiation of TG cultures, cells were scraped off the surface of the wells 
and total RNA was extracted from the cells using RNeasy™ columns (Quiagen, Valencia, CA) 
according to manufacturer’s instructions.  Total RNA was treated with DNase-1 using the DNA-
free™ kit according to manufacturer’s instructions (Ambion INC, Austin, TX). RT-PCR was 
performed using the GeneAmp® Gold RNA PCR core kit (Applied Biosystems, Foster City, 
CA). The cDNA encoding glycoprotein H and house keeping gene hypoxanthineguanine 
phosphoribosyl transferase (HPRT) were amplified and by using the following primer pairs 
through 40 cycles:  
The following primers were used: gH, left (TTT ATG GTT CGT GGG GGT TA); right 
(GGT CTT CGG GAT GTA AAG CA) and HPRT, left (CTG GTG AAA AGG ACC TCT CG), 
and right (TGA AGT ACT CAT TAT AGT CAA GGG CA). The reaction conditions for the RT 
were: 25°C for 10 min followed by 42°C for 12 min and for the PCR reaction: (i) Initial 
activation of AmpliTaq gold 95°C for 4min, (ii) annealing and extension at 95°C for 30 sec, 
55°C for 30 sec, and 72°C for 1 min and (iii) final extension at 72°C for 10 mins. 
3.11. In vivo Treatment of anti-IL2 
At various times post infection IL-15 -/- or C57BL/6 mice were treated IP with 1mg of anti-
IL-2 mAb (clone S4B6-1) diluted in 500 µl of endotoxin free PBS (Biowhittaker).  Anti-IL-2 
antibody was checked for endotoxin levels before use in in vivo studies.  
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 3.12. BrdU Stain 
 WT and IL15-KO mice were administered 1mg of anti-IL2 or PBS intraperitoneally (IP) 
at D6 PI.  All mice either received 1mg of BrdU (BD, Pharmingen) solution IP at D6 and at D7 
PI or equal volume of PBS (negative control).  The mice were sacrificed at D8 PI, the TG and 
the draining submandibular lymph nodes were extracted and a single cell suspension was 
obtained for each individual LN and TG for each mouse in the four experimental groups.  Each 
TG single cell suspension and 2 x 106 LN cells was washed and the Fc receptors were blocked.  
Cell surface proteins CD8α, CD4, CD45, and gB specific TCR was stained by incubating the 
single cell suspensions of TG and LNs with fluorochrome-conjugated antibodies and gB-MHC I 
dimer for 1 hr at 4°C. The cells were washed twice with flow wash buffer and resuspended in 
Cytofix/Cytoperm™ solution (BD Pharmingen) for 20 min at 4°C to fix and permeabilize.  The 
cells were washed once with 1X Perm/Wash™ buffer (BD Pharmingen) and incubated with 
Cytoperm Plus™ buffer for 10 min at 4°C.  The cells were washed once with 1X Perm/Wash™ 
and refixed for 5 min at 4°C with Cytofix/Cytoperm™ solution.  The cells were washed and 
resuspended in 100µl of DNase solution (300µg/ml) and incubated for 1hr at 37°C followed by 
incubation with 50µl of 1X Perm/Wash™ buffer containing fluorescent anti-BrdU and isotype 
control for 20 min at room temperature and analyzed immediately using a flow cytometer (BD, 
BSR II) 
 
3.13. Annexin-V Apoptosis Detection 
 WT and IL15-KO mice were administered 1mg of anti-IL2 or PBS intraperitoneally (IP) 
at D6 PI.  The mice were sacrificed at D8 PI, the TG and the draining submandibular lymph 
nodes were extracted and a single cell suspension was obtained for each individual LN and TG 
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 for each mouse in the four experimental groups.  Each TG single cell suspension and 2 x 106 LN 
cells was washed and the Fc receptors were blocked.  Cell surface proteins CD8α, CD4, CD45, 
and gB specific TCR was stained by incubating the single cell suspensions of TG and LNs with 
fluorochrome-conjugated antibodies and gB-MHC I dimer for 1 hr at 4°C were washed twice 
with cold PBS and then resuspended in 100µl of 1X binding buffer (BD Pharmingen) containing 
FITC-Annexin-V (BD Pharmingen) at a 1:20 dilution for 15 min at room temperature.  200µl of 
1X binding buffer was added to each tube before immediate flow cytometric analysis. 
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 4. RESULTS 
 
The contents of sections 4.1 - 4.5.2 have been modified from articles (33,73).  Copyright 
(2004), with permission from “Elevier” and “The American Society of Microbilogy”.  Copyright 
permission is on file with Kamal Khanna. 
4.1. Immune Infiltration into the Trigeminal Ganglion 
Background and Rationale:  
 
  Early studies with rabbit ocular infection models (147) first demonstrated the 
infiltration of T lymphocytes in the TG after corneal infection. Moreover the presence of 
cytokine transcripts (136) in the TG long after the establishment of latency indicated a continued 
immune response in the peripheral nervous system even though the virus was allegedly veiled 
from the immune system. These observations lead our laboratory to perform an in-depth 
histologic study of the TG after HSV-1 corneal infection in AJ mice.  CD8+ T cells invade the 
TG around 7 days after HSV-1 corneal infection, reach maximum density around 14 days post 
infection (p.i.), and are then retained in significant numbers seemingly for the life of the animal 
(36,22), therefore we employed flow cytometry to determine the kinetics and the phenotype of 
the CD8+ T cell immune response in the TG during acute and latent phases after HSV-1 corneal 
infection.    
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Figure 12: Infiltration of CD8+ T cells in the TG after HSV-1 corneal infection. Single-cell 
suspensions of TG obtained from mice 8, 14, 34, and 84 days after HSV-1 corneal infection were 
simultaneously stained for CD45 and CD8.  For each reaction the equivalent number of cells 
from 2 TGs were stained and a total of 5 x 105 events were collected. Forward and side scatter 
gates were set to encompass the CD45 population, and the frequency of CD8+ T cells was 
expressed as a percentage of CD45+ cells (% CD8). These data are representative of 2 - 4 
independent experiments. 
 
  Using flow cytometric analysis, we quantified CD8+ T cells and CD45+ cells (bone 
marrow-derived infiltrating cells) in ipsilateral (infected) and contralateral (uninfected) TG 
single-cell suspensions obtained at various times after uniocular HSV-1 corneal infection of 
C57BL/6 mice.  The highest density of CD8+ T cells was present in the ipsilateral ganglion 8 
days p.i., the population declined through day 34 p.i., and then a constant pool of CD8+ T cells 
was maintained at least through day 84 p.i (Figure 12).  In contrast, fewer than 100 CD8+ T cells 
were detected in the contralateral (uninfected) TG (not shown).  Recent reports have indicated 
that T lymphocytes migrate to many nonlymphoid tissues in response to a viral infection 
irrespective of the presence of antigen therefore we performed histological analysis of mouse TG 
after corneal infection to determine the distribution of CD8+ T cells within the three branches of 
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 the ganglion.Within the ipsilateral TG, CD8+ T cells were concentrated within the ophthalmic 
branch containing neurons that innervate the cornea (Figure 13).  The CD8+ T cells appear to 
surround the neurons and are in close apposition to the neuronal cell bodies only in the 
ophthalmic branch of the ganglion, which contains neurons that innervate the cornea.  HSV-1 
uniformly established a latent infection in the TG neurons by 14 days p.i. as demonstrated by a 
lack of replicating virus in extracts of freshly isolated TG obtained 14 and 34 days p.i. (data not 
shown).  Thus, CD8+ T cells are selectively retained in infected regions of the TG long after viral 
latency is established.   
DIC CD8 Merge
TG Ophthalmic Branch
TG Maxillary Branch
 
 
Figure 13: Selective retention of CD8+ T cells in latently infectecd tissues. TG were excised 34 
days after HSV-1 corneal infection, and frozen sections were stained for CD8.  Representative 
fields from the ophthalmic (A) and maxillary (B) branches of the TG are shown.  Superimposed 
fluorescence and DIC images show preferential accumulation of CD8+ T cells (red) among the 
neuronal cell bodies in the ophthalmic branch of the latently infected TG. 
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 4.1.1. Activation Phenotype of CD8+ T cells in the TG 
 Single-cell suspensions of TG obtained from C57BL/6 mice at various times after 
uniocular HSV-1 corneal infection were simultaneously stained for CD45, CD8, and for either 
the CD69 (early activation) or CD44 (activation/memory) markers (Figure 14).  In the ipsilateral 
TG, CD44 was consistently expressed on CD8+ T cells from day 8 through day 84 p.i. (Figure 
14A).  In contrast, the percentage of CD8+ T cells that expressed CD69 was very low at 8 days 
p.i., increased through day 34 p.i., and then remained constant through day 84 p.i. (Figure 14B).  
The CD8+ T cells in the TG also showed a shift to elevated expression of CD8 between day 8 
and day 34 PI (Figure 14C).  These findings demonstrate that CD8+ T cells were activated in the 
TG after viral latency was established and the TG CD8+ T cell population exhibits a shift to a 
more activated phenotype during the course of latency. 
Day 8 p.i.
A B
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Figure 14: Activation phenotype of CD8+ T cells present in the TG. Single cell suspensions of 
TG were analyzed for expression of: (A) CD44, (B) CD69, (C) CD8 (dashed lines), or isotype 
control (dark line).  Following flow cytometric analysis, the forward angle and side scatter gates 
were set on the CD45+ population.  Backgating on the CD8+ population determined the 
proportion of CD8+ T cells that expressed the activation markers.  These data are representative 
of 2 - 4 independent experiments. 
 
4.2. Antigen Specificity of CD8+ T cells in the TG 
Backgound and Rationale:  
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 Previous studies have shown that the CTL response to HSV-1 infection in the lymph 
odes consists of T cells specific for the immunodominant gB epitope (glycoprotein B) and for 
the subdominant epitope RR1 (ribonucleotide reductase) (121,123,141,146).  However, we have 
shown that in the TG IE protein ICP4 and early protein ICP8 are expressed in a fraction of the 
neurons that harbor latent virus in vitro (32), and other studies have demonstrated the presence of 
IE transcripts in latently infected TGs (30).  Therefore we hypothesize that the differences in 
antigen presentation and the state of viral replication between the primary sites and the peripheral 
nervous system will influence the phenotype of the CD8+ T cells that infiltrate and remain in the 
TG.  In addition, the antigen specificity and immunodominant determinants of the CD8+ T cells 
may vary at different times PI.  The state of latency at early time points like day 14 may be 
different from later time points such as day 30 or 60 because of factors like differential MHC 
class I expression on neurons early vs. late PI (138,139).  Data from our laboratory shows that at 
14 days PI the endogenous CD8+ T cells can protect sensory neurons from reactivation in vitro 
but at day 34 exogenous CD8+ T cells are required (32).  Other studies have provided evidence 
for epitope shifting in a neurotropic persistent viral infection. They showed that the majority of 
the CD8+ T cells that infiltrate the CNS upon infection are cytolytic and are specific for a certain 
epitope but at later time points after infection there is a shift in the epitope specificity of the T 
cells along with the loss of cytolytic function (148).  We therefore hypothesize that the nature of 
the CD8+ T cell response may be quite dissimilar during the lytic (day 5-7), early latent infection 
(day 14) and at later time points during latency (day 30 and 60) in the trigeminal ganglion.  
Using tetramers and intracellular cytokine stain we identified the antigen specificity of the CD8+ 
T cells and the nature of immunodominance at various times after corneal infection in the TG. 
Results: 
n
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Figure 15: CD8+ T cells retained in the TG during latency are specific for HSV-1 protein gB 
nd produce IFNγ directly ex vivo.  Single cell suspensions of TG obtained 14 days after 
The antigen specificity and the ability of  the CD8+ T cells to secrete IFNγ in the HSV-1 
latently
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corneal infection were incubated with the indicated stimulator cells for 6 hours in the presence 
of GolgiPlug™ and stained for intracellular IFNγ.  The stimulator cells were HSV infected (HSV 
stimulated), gB498-505 peptide pulsed (gB stimulated), RR1 pulsed (RR1 stimulated) or uninfected 
(Unstimulated). 
 
 
 infected C57BL/6 TG was determined by stimulating the TG-derived lymphocytes for 6 
hours with HSV-1 infected or gB498-505 transfected stimulator cells, and then staining 
simultaneously for CD45, CD8, and intracellular IFN-γ.  In TG obtained 14 days PI, a similar 
percentage of CD8+ T cells produced IFN-γ when stimulated with HSV-1 infected (21.5 ± 3.3%) 
or gB498-505 peptide-pulsed (20.0 ± 0%) stimulator cells (Figure 15).  Thus, it appears that most 
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 HSV-specific CD8+ T cells in the TG 14 days p.i. are specific for the immunodominant gB498-505 
peptide, but the majority of these are incapable of producing IFN-γ when stimulated.   
 
 
igure 16: Ant Single cell suspensions of TG 
btained at 14 days PI were stained with an anti CD8 mAb, anti CD45 mAb, and either gB498-
lternatively, antigen specificity of CD8+ T cells was also determined by staining TG-derived 
CD8
F igen specificity of CD8+ T cells in the TG.  
o
505/K  or RR1b 822-829/K  tetramers.  A total of 5 x 10  events were collected.  The dot plots 
represent the CD8 gated population.  These data are representative of 2 - 4 experiments. 
 
 
b 5
A
lymphocytes with tetramers containing the immunodominant gB498-505 or subdominant 
ribonucleotide reductase 1 (RR1822-829) epitopes.  Surprisingly, a much higher percentage of 
CD8+ T cells reacted with the gB tetramer (58.0 ± 2.0%) compared to the ability of these cells to 
secrete IFNγ directly ex vivo (comapare figure 16 and 15).  CD8+ T cells reactive to a 
subdominant epitope on RR1 were low to undetectable by both tetramer staining and IFN-γ 
production (Figure 16 and 15).  Therefore there is a strong skewing towards one 
immunodominant viral determinant, gB, the majority of the CD8+ T cells in the TG by 14 days 
PI are specific for the late viral protein glycoprotein B.   
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Figure 17: CD8+ T cells retained in the TG at 34 days PI during latency can secrete IFNγ 
directly ex vivo.  Single cell suspensions of TG obtained 34 days after corneal infection were 
incubated with the indicated stimulator cells for 6 hours in the presence of GolgiPlug™ and 
stained for intracellular IFNγ.  The stimulator cells were HSV infected (HSV stimulated), gB498-
505 peptide pulsed (gB stimulated), RR1 pulsed (RR1 stimulated) or uninfected (Unstimulated). 
 
 
At 34 days p.i. (Figure 17) there was a similar proportion of CD8+ T cells in the TG that 
produced IFN-γ in response to HSV-1 infected (43.0 ± 3.5%) and gB498-505 peptide-pulsed (47.0 
± 3.0%) stimulator cells.  However, the proportion of CD8+ T cells that produced IFN-γ in 
response to either stimulation was significantly higher at 34 days than at 14 days p.i. (compare 
Figure. 17 and 15).   
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 Figure 18: Antigen specificity of CD8+ T cells in the TG at 34 days PI.  Single cell suspensions 
of TG obtained at 34 days PI were stained with an anti CD8 mAb, anti CD45 mAb, and either 
gB498-505/Kb or RR1822-829/Kb tetramers.  A total of 5 x 105 events were collected.  The dot plots 
represent the CD8 gated population.  These data are representative of 2 - 4 experiments. 
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The proportion of CD8+ T cells in the day 34 TG (Figure 18) that recognized the gB498-505 
tetramer (62.0 ± 2.0%) was similar to that observed in day 14 TG.  Thus, in the latently infected 
TG, there is selective enrichment of gB-specific CD8+ T cells capable of producing IFN-γ, 
however there is no indication of an epitope shift between early vs. late time points during 
latency 
Simultaneous in situ tetramer and immunofluorescence staining of whole TG obtained 34 
days after HSV-1 corneal infection demonstrated selective localization of gB498-505 tetramer 
positive CD8+ T cells within the ophthalmic branch of the TG (Figure 19)  
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Figure 19: In situ tetramer stain of latently infected TG. TG were excised and gB498-505-specific 
CD8+ T cells were identified by simultaneously staining the whole tissue with MHC class I 
tetramers containing the gB498-505 epitope (green) and CD8 (red).  The tissues were examined by 
confocal microscopy, and presented as a merged image of a Z-series.  Areas of overlap between 
the CD8 and tetramer-bound TCR appear yellow.  (A-C) The majority of CD8+ T cells that 
localized to the area of neuron cell bodies in the ophthalmic branch of the TG were tetramer 
positive.  RR1 tetramer was used as negative control. (D-F) Note the lack of RR1 tetramer 
staining on CD8+ T cells in the ganglion.  
 
 
The majority of the CD8+ T cells were observed to be gB498-505 tetramer positive, and 
these cells were localized to the area of the ophthalmic branch containing neuron cell bodies.  No 
RR1 tetramer positive cells were observed (Figure 19), which agreed with the flow data, and 
served as a negative control for tetramer staining.  In most gB498-505 tetramer positive cells, 
tetramer staining was polarized and appeared patchy or ring-shaped, suggestive of immunologic 
synapse formation.  The ring-shaped staining pattern might reflect an immature synapse, or the 
fact that the tetramer can only bind to TCR that are not engaged by the epitope on the target cell 
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 or that can be competed off the cell-bound epitope by the tetramer.  Thus, tetramer competition 
for TCR binding in the central region of the synapse might be more demanding than that at the 
periphery of the synapse, resulting in a ring of staining around the synapse.  
 In many of the gB498-505 tetramer positive CD8+ T cells, the TCR was polarized to the 
area of the cell that appeared to be in direct contact with a neuron (Figure 20), consistent with the 
notion that gB498-505 tetramer positive CD8+ T cells can directly monitor viral gene activity in 
latently infected neurons.   
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Figure 20: T cell receptor polarization towards neuronal cell bodies.  (A-H) Most of the CD8+ 
T cells exhibited ring- or patchy-foci of TCR polarization.  (D and H) Grayscale image showing 
CD8+ T cells (arrows) in direct apposition to neurons (arrowheads); taking advantage of the 
intrinsic autofluorescence of neurons when excited with an argon laser and collected with a 500 
longpass filter. Simultaneous staining of whole TG tissue with gB498-505 MHC class I tetramers 
(green) and CD8 (red).  Colocalization of TCR and CD8  appears as green. 
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 Figure 20 (A-D and E-H) shows two such examples exhibiting the possibility of CD8+ T cells 
directly interacting with neuronal cell bodies presumably harboring latent virus.  The presence of 
a distinct TCR polarization suggests formation of an organized immunological synapse with the 
neurons of t
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 To further investigate the likelihood of gB specific CD8+ T cells directly interacting with 
neurons in the latently infected TG we took advantage of the Metamorph software and derived 
orthogonal zy and xz views of the CD8+ T cells that show or do not show gB specific TCR 
polarization (Figure 21).  The orthogonal yz views in Figure 21A-C clearly show gB specific 
TCR aggregation in an organized immunological synapse exhibiting the formation of a cSMAC 
on those CD8+ T cells that were in close apposition to neurons in the TG.  Note the dispersed 
TCR (Figure 21D) on the surface of a CD8+ T cell that did not exhibit receptor polarization and 
was not in close proximity to a neuron (compare Figure 21C and D).  To our knowledge this is 
the first example of a demonstration of the formation of an immunological synapse in vivo and a 
direct interaction of CD8+ T cells with neurons.   
 
4.3. Expression of Glycoprotein B During Latency 
Background and Rationale: 
 
 CD8+ T cells retained in the TG during latency appear to be activated as demonstrated by 
their activation phenotype, antigen directed retention only in the infected ipsilateral TG and the 
appearance of direct interaction with neurons as well as formation of an organized 
immunological synapse with neuronal cell bodies.   These data suggest that a late (γ1) viral gene 
product may be presented to CD8+ T cells even during latency and may explain the state of CD8+ 
T cells in the latent TG.  To investigate this possibility we performed RT-PCR on whole TG 
tissues that were latently infected with HSV-1 using gB specific primers, but we obtained 
variable results.  We had difficulties in obtaining consistent clear results with the RT-PCR 
approach because the gB gene is an unspliced gene, which prevented us from using intron 
spanning primers.  To avoid these complexities we constructed a recombinant virus that 
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 expresses enhanced green fluorescent protein (EGFP) under the control of the gB promoter 
(gBp-EGFP HSV-1), therefore we were able to detect gB promoter activity in vivo.   
Results: 
 
Figure 22: Confocal images of whole TG 5 days after corneal infection with gBp-EGFP HSV-
1. Whole TGs were excised 5 days PI, and stained for CD8α (red) and gB promoter activity is 
exhibited by green fluorescent protein (green). At 5 days PI replicating virus can be seen in 
neurons (green) of the ophthalmic branch of the TG (A).  CD8+ T cells (red) are beginning the 
infiltration in the TG and can be seen in close apposition to green neurons (B), and also axons 
exhibiting gB promoter activity (C). 
C
B
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 Using whole tissue staining and confocal microscopy we were able to detect expression 
of the gB gene in vivo during acute HSV-1 infection (D5 PI; Figure 22).    CD8+ T cells appear 
to interact with neurons and axons showing evidence of gB promoter activity suggesting antigen 
presentation by neuronal cells to CD8+ T cells. 
 To determine if gB, a γ1 gene product, is expressed during latency mice were infected 
with the gBp-EGFP HSV-1 and sacrificed at 34 days PI, TGs were excised and whole tissues 
were analysed by confocal microscopy to detect expression of EGFP as a function of gB 
promoter activity. 
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Figure 23: Whole mounts of TG infected with gBp-GFP HSV-1 34 days PI. Mice were infected 
with gBp-GFP HSV-1 and sacrificed at 34 day after corneal infection.  TGs were excised and 
green fluorescence was detected by confocal microscopy. 
 
  
As shown in Figure 23 three to four neurons exhibited GFP expression indicating gB 
promoter activity confirming the possibility of γ1 gene expression during latency and continued 
antigen presentation to CD8+ T cells retained in the TG after the establishment of latency.  
Interestingly in some neurons GFP was detected localized in the nucleus (Figure 23).   
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 4.4. Role of CD8+ T Cells in Preventing Reactivation and Control of Viral Gene   
Expression during Latency 
 
Background and Rationale: 
 
 The data presented above indicate that CD8+ T cells infiltrate the TG at a time when 
HSV-1 replication has nearly ceased and latency is beginning to be established.  The CD8+ T 
cells remain in the TG seemingly for the life of the animal, moreover the CD8+ T cell population 
exhibits a shift to a more activated phenotype during the course of latency.  Earlier work by 
Simmons’ group has established the role of CD8+ T cells in controlling viral replication during 
lytic infection in the sensory ganglion (132).  Furthermore studies with of αβ T cell-deficient 
mice have revealed that after HSV-1 corneal infection the virus was largely controlled early, but 
the majority of the mice died as a result of encephalitis presumably as a result of poor 
maintenance of viral latency (130).  HSV-1 does not appear to spontaneously reactivate from 
latency in the sensory ganglia of mice in vivo.  However, the virus can reactivate from mouse 
ganglion in vitro; we hypothesize that the capacity of HSV-1 to reactivate from latency in 
explant cultures of mouse ganglia might reflect the separation of the ganglionic neurons from 
HSV specific CD8+ T cells.  Our histologic studies indicate that CD8+ T cells are not only 
retained in the TG long after the establishment of latency, but they appear to interact directly 
with neurons and form an organized immunological synapse, which suggests continued antigen 
presentation to gB specific CD8+ T cells by latently infected neurons.  The possibility of antigen 
presentation to CD8+ T cells in the ganglion by neurons is further strengthened by the results 
obtained by infection of mice with gBp-EGFP HSV-1 (Figure 23) demonstrating the expression 
of gB in latently infected neurons. 
 
Results:   
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  The above findings invited the hypothesis that CD8+ T cells specific for a single 
immunodominant epitope of the HSV-1 γ1 gene product gB can block HSV-1 reactivation from 
latency.   
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Figure 24: A CD8+ T cell clone specific for the gB498-505 epitope (2D5) can block HSV-1 
reactivation from latency in TG cultures.  TG were excised from C57BL/6 mice 34 days after 
corneal infection and TG cells (0.5 TG equivalent/culture) were cultured with the indicated 
CD8+ T cells, 1x105, 5x104, or 1x104 2D5 cells (n=10) and naïve cells (n=5).  At the indicated 
times cultures were examined and HSV-1 reactivation was monitored as described in Methods.  
A Survival Curve Analysis determined the significance of differences in reactivation frequency 
(compared to cultures receiving naïve CD8+ T cells).  (*** p< 0.0001). The reactivation 
frequency in cultures that received naïve CD8+ T cells was not significantly different (p = 
0.5485) from that in cultures to which no CD8+ T cells were added.  
 
 
To investigate this point, cultures were prepared with single cell suspensions of C57BL/6 
TG that were excised 34 days after HSV-1 corneal infection.  To these cultures were added: 1) 
varying numbers of 2D5 cells, an HSV gB498-505 peptide-specific CD8+ T cell clone derived from 
C57BL/6 mice; 2) naïve CD8+ T cells isolated from the lymph nodes of uninfected C57BL/6 
mice; or 3) no CD8+ T cells.  The cultures were then monitored for HSV-1 reactivation as 
described in Methods.  All cultures that received 1 x 105 naïve CD8+ T cells exhibited HSV-1 
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 reactivation with similar kinetics to that observed in cultures to which no CD8+ T cells were 
added.  The addition of 2D5 cells to MHC compatible C57BL/6 TG cultures suppressed HSV-1 
reactivation in a dose-dependent manner (Figure 24).  At inputs of 1 x 105 and 5 x 104, 2D5 cells 
significantly (p< 0.0001 and p < 0.001, respectively) suppressed HSV-1 reactivation from 
latency in C57BL/6 TG cultures throughout the 10-day culture period.  In contrast those cultures 
that received 1 x 104 2D5 cells, naïve CD8 T cells or no cells reactivated promptly and by day 10 
after culture initiation 100% of them had replicating virus.    
 
100 4 6 8
0 
20 
40 
60 
80 
100 
Days after culture initiation
%
 R
ea
ct
iv
at
io
n Naïve CD8 T cells
1x105 2D5 Cells  
Figure 25: 2D5 cells cannot block HSV-1 reactivation in allogeneic D34 Balb/c TG cultures. 
TG were excised from Balb/c mice 34 days after corneal infection and TG cells (0.5 TG 
equivalent/culture) were cultured with the indicated CD8+ T cells, 1 x 105 2D5 cells (n=8) and 
naïve CD8+ T cells (n=5).  At the indicated times cultures were examined and HSV-1 
reactivation was monitored as described in Methods.   
 
 CD8+ T cells can produce many antiviral factors such as cytokines and the proposed 
CD8+ T cell antiviral factor (CAF) that does not require cell-cell interaction or MHC restriction 
(149).  To determine if the CD8+ T cell protection from reactivation in the ex vivo cultures is 
MHC restricted, single cell suspensions of Balb/c TG that were excised 34 days and cultured as 
mentioned above.   In contrast to C57BL/6 cultures (Figure 24) at the highest input (1 x 105 
60 
 cells/culture) 2D5 cells did not significantly (p = 0.45) alter the course of HSV-1 reactivation 
from latency in the MHC incompatible BALB/c TG cultures (Figure 25), suggesting that the 
protection rendered by CD8+ T cells in the TG ex vivo cultures is indeed MHC restricted and 
presumable requires cell-cell contact.   
 Since the TG cultures in the above experiment contained host CD8+ T cells that were 
present in the TG at the time of excision, the relative contribution of the endogenous CD8+ T 
cells and added 2D5 cells could not be determined.  To address this issue, TG were excised 34 
days after HSV-1 corneal infection of C57BL/6, and depleted of CD8+ T cells by 
immunomagnetic separation.  Either 2D5 cells or naïve syngeneic CD8+ T cells were then added 
to the CD8-depleted TG cultures, and the cultures were monitored for HSV-1 reactivation.  
Again, naïve CD8+ T cells failed to influence HSV-1 reactivation from latency, while 2D5 cells 
inhibited HSV-1 reactivation from latency in a dose-dependent manner (Figure 26). 
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Figure 26: 2D5 Cells Can Block HSV Reactivation in CD8-Depleted Day 34 C57BL/6 TG 
cultures.  TG were excised from C57BL/6 mice, depleted of endogenous CD8+ T cells, and 
cultured with 1x105 (n=15) or 1x104 (n=20) 2D5 cells, or with 1x105 naïve CD8+ T cells (n=16). 
At the indicated times cultures were examined and HSV-1 reactivation was monitored as 
described in Methods.  A Survival Curve Analysis determined the significance of differences in 
reactivation frequency (compared to cultures receiving naïve CD8+ T cells (*** p< 0.0001). 
 
The 2D5 cells are cytotoxic and produce IFN-γ when stimulated with the gB498-505 
epitope.  However, treating TG cultures with anti-CD8 mAb 6 days after culture initiation 
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 blocked
leted 
o cultures.  
 the 2D5 protective function and allowed the previously latent virus to reactivate as 
indicated by the cytopathic effect (CPE) of the virus (not shown).   The prompt reactivation after 
the addition of anti-CD8 mAb suggests that 2D5 cells could prevent HSV-1 reactivation in TG 
cultures without eliminating the reservoir of latenly infected neurons.  In addition protected TG 
cultures did not show any expression of the γ2 gene, gH (Figure 27).  However γ2 gene 
expression was readily detected in cultures that reactivated as a result of the addition of anti-CD8 
mAb.   Thus, 2D5 cells were able to block HSV-1 reactivation in at least some of the neurons by 
a non-cytolytic mechanism and by regulating viral gene expression.   
 
C57BL/6 TG Cultures
Figure 27: gB specific CD8+ T cell clone can block HSV-1 γ2 gene expression in D34 TG 
cultures. Ten days after culture initiation, total RNA was extracted from CD8+ T cell-dep
TG cultures that received 1x105 2D5 cells, and was analyzed for HSV-1 gH transcripts by RT-
PCR as described in Methods.  Each sample is comprised of pooled RNA from tw
2D5 Cells 2D5 Cells + αCD8 HSV RNA 
Lanes 1-4 represent cultures that did not receive anti-CD8 mAb and showed no viral CPE or 
infectious virus.   Lanes 5-8 represent cultures that received anti-CD8 mAb on day 6 of culture 
and were positive for viral CPE and infectious virus.  Note that the cultures represented in 
columns 7 & 8 were nearly destroyed by the virus, resulting in greatly reduced total RNA and gH 
transcripts.  RNA extracted from a freshly excised TG obtained 5 days after corneal infection 
(during lytic virus infection) served as a positive control (lanes 9 and 10).  Transcripts for the 
housekeeping gene HPRT were similarly amplified to demonstrate equal loading of RNA from 
each sample. 
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Figure 28: IFN-γ supernatant fluids from the 
cultures described in Figure. 24  content by ELISA.  Data are 
presented for undepleted (A) and CD8 TG cultures that received 
1x105 2D5 cells, or 1x10
ore, supernatant fluids from the cultures shown 
γ by ELISA (Figure 28).  C57BL/6 TG cultures 
containing endogenous CD8
 production in TG cultures.  At the indicated times, 
and 26 and were tested for IFN-γ
+ T cell depleted (B) C57BL/6 
5 naïve CD8+ T cells.    
 
We have demonstrated that IFN-γ can block HSV-1 reactivation (see next result section) 
from latency in ex vivo TG cultures (73). Theref
in Figure 24 and 26 were tested for IFN-
+ T cells, but no added CD8+ T cells produced significant amounts of 
63 
 IFN-γ, but only after HSV-1 reactivated from latency (Figure 28A and 24, respectively).  
C57BL/6 TG cultures that were depleted of endogenous CD8+ T cells and did not receive 2D5 
cells, or received naïve CD8+ T cells produced low to undetectable levels of IFN-γ even after 
HSV-1 reactivation from latency (Figure 28B and 26, respectively) demonstrating that HSV-
specific CD8+ T cells are responsible for most or all IFN-γ production in these cultures.   
Interestingly, the cultures that received a protective dose of 2D5 cells (1x105/culture) 
showed early production of IFN-γ on days 4 and 6 of culture, and the IFN-γ levels declined 
thereaf
4.5. Mechanisms Employed by CD8  T cell to Prevent HSV-1 Reactivation 
Background and Rationale: 
Our studies have provided compelling evidence that CD8+ T cells can prevent 
 in ex vivo TG cultures, but the mechanisms by which the CD8+ T 
cells c
ter.  These data suggest that the addition of exogenous gB-specific CD8+ T cells to the TG 
cultures allows more rapid interaction with reactivating neurons, thus permitting a protective 
CD8+ T cell response within the timeframe necessary to block HSV-1 reactivation from latency.  
Together these findings demonstrate that CD8+ T cells can block HSV-1 reactivation from 
latency in TG cultures by a gB-specific, dose-dependent, MHC-restricted, non-cytolytic 
mechanism that is at least partially IFN-γ-dependent. 
 
+
 
reactivation of latent HSV-1
onfer such protection are yet to be fully understood.  Two of the most common 
mechanisms utilized by CD8+ T cells to eliminate invading pathogens are secretion of antiviral 
cytokines and destruction of virus infected cells through induction of apoptosis through the 
release of lytic granules containing perforin, GrA and GrB.   
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  HSV-1 infection of mice results in a latent infection in sensory ganglia, but the virus 
does not normally reactivate from latency.  There is a substantial infiltration of CD4 and CD8+ T 
cells, w
estruction of viral infected cells through apoptosis.  Fas mediated destruction 
of targe
hich are retained in the TG seemingly for the life of the animal.  Moreover leukocytic 
infiltration of the latently infected mouse TG is associated with the presence of T cells secreted 
cytokines IFNγ, TNFα and IL-6 suggesting persistent activation of the infiltrating cells 
(136,129,22).  Cytokine production in the TG was inhibited by treatment of latently infected 
mice with the antiviral drug acyclovir (ACV), consistent with the involvement of viral proteins 
in T cell activation.  Results from studies in our and other laboratories are consistent with the 
notion that individual latently infected neurons may periodically lose the capacity to inhibit 
expression of HSV-1 genes, resulting in low-level and perhaps intermittent production of viral 
proteins.  These viral proteins (such as γ1 gene product gB; see sections 4.2 and 4.3) might 
stimulate T cells in the ganglion to produce cytokines and perhaps degranulation of cytolytic 
granules that prevent further progression through the viral life cycle to the stage of virion 
production.  Therefore in the next set of studies we determined the role of IFNγ and the lytic 
machinery (perforin and Fas-FasL mechanisms) in preventing reactivation of latent HSV-1 in ex 
vivo TG cultures.   
One of the most potent mechanisms utilized by CD8+ T cells is the Fas (CD95) and 
perforin mediated d
t cell operates through the binding of Fas receptor on the infected cell with the Fas ligand 
(FasL) on the CD8+ T cells.  This Fas-FasL binding triggers the release of cysteine proteases 
called caspases, that lead to the death of the infected target cell.  The second mechanism by 
which target cells are destroyed by CD8+ T cells is the release of a pore forming molecule 
perforin (68kDa) from granules.  Upon recognition of foreign antigens presented by class I major 
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 histocompatibility complex (MHC-I) on infected cells the granules present in the CD8+ T cells 
are activated and perforin is subsequently released.  T cell mediated cytolysis involves granule 
components such as; perforin, serine protease GrB and GrA (60,150).  Perforin polymerization in 
target cell membranes facilitates entry of granzymes.  However recent studies have shown that 
perforin also plays an important role in redistribution of granzymes once these molecules enter 
the cytoplasm.  Perforin may be essential for nuclear translocation of granzymes as well as their 
release from endosomal vesicles (66,151,152).  Once in the cytoplasm of the target cell, GrA and 
GrB are believed to function independently initiating separate pathways. GrB (32 kDa) is 
proteinase with aspase activity and cleaves at aspartate residues (66), it is believed to be the more 
potent of the two granzymes and induces apoptosis rapidly.  GzmB can activate cysteinyl 
aspartate-specific proteinases (caspases) by directly cleaving them at specific aspartate residues. 
Once activated caspases can activate each other.  Activated caspases translocate to the nucleus 
and begin the destruction of DNA repair enzymes such as poly (ADP-ribose) polymerase 
(PARP) and DNA dependent protein Kinase (DNA-PKcs). In addition, GrB has been reported to 
directly cleave PARP and DNA-PKc increasing the efficiency and rate of apoptosis.  The 
ultimate result of such events is lack of DNA repair and eventual fragmentation of cellular DNA 
(66,153).  The exact mechanism employed by GrA in apoptosis or viral clearance has not yet 
been completely elucidated, however it appears to function independently of GrB (69,154,70).  
GrA (65kDa) is a tryptase with specificity for basic residues such as lysine or arginine and is 
thought to activate a caspase independent apoptotic pathway.  The contribution of GrA in target 
cell apoptosis is a subject of controversy, a recent study identified a GrA activated DNase called 
NM23-H1. NM23-H1 is a tumor suppressor protein and is responsible for inducing cell-death 
events such as DNA damage. An inhibitor protein SET keeps NM23-H1 inactivated in the 
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 cytoplasm, GrA cleaves SET allowing NM23-H1 to translocate to the nucleus and cause DNA 
damage (155).   Shresta et al, propose a model for the pathways of GrA and GrB function.  They 
suggested that GrB is the primary inducer of apoptosis but in certain instances, such as GrB 
resistant tumors and infections with viruses that encode proteins to inhibit GrB (CrmA encoded 
by cowpox virus) GrA can be very valuable (70).  There are limited data on the role of 
granzymes in HSV-1 infection; a recent study implicated GrA in preventing HSV-1 neuronal 
spread in the TG at 5 days after HSV-1 corneal infection.  At 5 days PI TGs isolated from GrA-/- 
mice contained considerably higher PFU of HSV-1, in addition many more neurons (10 fold 
higher) were infected with HSV-1 in TG of GrA-/- mice compared to WT mice. Apart from its 
ability to cause target cell death, there are many noncytolytic functions that have been proposed 
for GrA, such as facilitating T cell migration and extravasation into subendothelial spaces, 
augmenting an inflammatory response mediated by IL-1 and IL-6 and perhaps acting as a 
cytokine itself (151,156). GrA activates pourokinase, initiating a proteolytic cascade leading to 
the production of plasmin, which in turns can inactivate enveloped viruses (Ectromelia virus) 
(157,67).  Interestingly GrA can cleave extracellular matrix proteins and thrombin receptors on 
neurons. (158).  Simmons et al, recently demonstrated the important role of GrA in restricting 
HSV-1 spread in mouse TG during the lytic phase of infection (133), however the role of the 
lytic machinery during latency is yet to be defined. 
Results: 
4.5.1. IFNγ Can Prevent HSV-1 Reactivation from Latency in Sensory Neurons 
 our previous study using Balb/c mice (32), when TG were obtained 34 days PI, the 
endogenous CD8+ T cells could delay, but could not prevent, reactivation, unless supplemented 
with exogenous CD8+ T cells obtained from the lymph nodes of HSV-1 infected, but not 
 In
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 uninfected, mice.  This failure of the endogenous CD8+ T cells to block reactivation in day 34 
Figure 29: rIFNγ alone cannot block HSV-1 reactivation. TG were excised 35 days after HSV-
1 corneal infection.  Single cell suspensions were prepared, and replicate cultures were 
incubated in culture medium alone (control) or medium containing rIFNγ.  The supernatant 
fluids were sampled every day and assayed for infectious virus.  The data are expressed as 
percentage of cultures with detectable virus.   
  
TG cultures might reflect their reduced numbers (compared to those of day 14 TG cultures), but 
it might also reflect functional change in the CD8+ T cells that remain in the TG between 14 and 
34 days after HSV-1 infection. To determine if IFNγ can prevent HSV-1 reactivation in ex vivo 
TG cultures balb/c TG were excised 35 days after corneal infection, dissociated into single cell 
suspension and cultured (1TG/well) in 24 well plates.  The cultures were incubated in medium 
alone or with recombinant IFNγ (rIFNγ; 1000 U/ml).  Reactivation was monitored by assaying 
the supernatant for infectious virus by plaque assay.  100% of the cultures reactivated in the 
presence or absence of rIFNγ (Figure 29).  The rate of reactivation was slightly delayed, the viral 
titers were slightly reduced (not shown), and reversion to undetectable virus titers occurred 2 
days earlier in rIFNγ-treated cultures.  However, none of these differences were statistically 
significant at a P value of <0.05. 
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  The findings described above (Figure 29) led us to propose that latent HSV-1 began to 
into th that 4 days of exposure 
ons and enhance the 
effectivenes  latency.  To test 
es were then 
γ at 0, 
oval of ACV 
atment was delayed until 48 hrs after removal of ACV. 
hr (n=25), 24 hrs (n=10), or 72 hrs (n=10) after removal of ACV. Culture supernatant were 
V-1 by plaque assay.  Reactivation 
γ 
treatment at 0 and 24 hrs only. 
 
reactivate early after TG excision, and by the time of culture initiation, it had progressed too far 
e viral life cycle to be controlled by IFNγ.  Therefore, we reasoned 
to the antiherpetic drug ACV would reestablish latency in all neur
s of IFNγ and CD8+ T cells in blocking HSV-1 reactivation from
this possibility, day 35 TG cultures were incubated for 4 days with ACV.  The cultur
incubated in culture medium alone or culture medium that was supplemented with rIFN
24, 48, or 72 hrs after removal of ACV.  Addition of rIFNγ within 24 hrs after rem
dramatically reduces HSV-1 reactivation from latency in TG cultures (P < 0.001; Figure 30).  
However, rIFNγ had no effect on HSV-1 reactivation on HSV-1 reactivation from latency when 
tre
 
Figure 30: IFNγ can block HSV-1 reactivation from latency in ACV treated TG cultures.  Day 
35 TG cell cultures were treated with ACV (50 µg/ml) for 4 days, rinsed and then incubated for 
an additional 10 days in medium alone (n=26) or culture medium supplemented with rIFNγ at 0 
sampled every other day and assayed for infectious HS
frequency was significantly reduced (P < 0.001) relative to medium only controls by IFN
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  Interestingly, IFNγ production was not detectable during ACV treatme
oval, it was produced with similar kinetics to that seen in cultures that were not trea
with ACV (data not shown).  Depletion of CD8+ T cells from the TG cell suspension
 production.  Thus, CD8+ T cells were the main source of IFNγ in cultures of
infected TG, and ACV delayed IFNγ production.  ACV at concentrations of up to 200µg/m
not significantly affect IFNγ production by 2D5 cells in response to stimulator cells that express 
opriate viral epitopes.  Thus, a direct ACV block of IFNγ production by CD8
nt, and following 
ACV rem ted 
 eliminated 
IFNγ  latently 
l did 
the appr + T cells 
annot account for the delay in IFNγ production observed in ACV-treated TG cultures.   
  
Figure 31: IFNγ can directly and indirectly inhibit HSV-1 reactivation from latency. TG were 
CD45+ cells (n = 12), and incubated with culture medium containing ACV for 4 days. After 
rIFNγ for an additional 10 days. Culture supernatant fluids were sampled every other day and 
e assay. 
IFNγ significantly reduced the reactivation frequency (P < 0.001) in CD45+ cell-depleted TG 
cultures. 
 
 
c
excised 35 days after HSV-1 corneal infection and single cell suspensions were pooled, depleted 
removal of ACV, cultures were incubated with medium alone or medium supplemented with 
assayed for infectious HSV-1 (indicating HSV-1 reactivation from latency) in a plaqu
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 Data in Figure 30 clearly established that IFNγ could prevent HSV-1 reactivation from 
latenc + 
 of excision.  Thus, it 
was not  latency in neurons or acted 
+ T cells and 
 supplemented 
with rIFN asured on alternate days. 
tion was delayed and significantly reduced in cultures that were treated with 
ultures that contained CD8+ T cells. These data demonstrate that IFNγ can block HSV-1 
activation from latency by a mechanism that is at least partially CD8+ T cell independent but is 
ineffec
uced 
HSV-1
y when present early in the reactivation process.  However these cultures contained CD8
T cells and other inflammatory cells that were present in the TG at the time
 clear if IFNγ directly blocked HSV-1 reactivation from
indirectly by enhancing a protective response of CD8+ T cells or other inflammatory cells.   
To address this issue, day 35 TG cell suspensions were depleted of CD8
incubated with ACV for 4 days. After removal of ACV, medium alone or medium
γ was added, and HSV-1 titers in culture supernatants were me
HSV-1 reactiva
rIFNγ (data not shown) (P < 0.001). It is noteworthy that rIFNγ did appear to be somewhat less 
effective at blocking HSV-1 reactivation in the absence of endogenous CD8+ T cells (60% versus 
20%, data not shown).  Moreover, rIFNγ treated CD8 T-cell-depleted TG cultures that 
reactivated were ultimately destroyed by the virus. As noted above, the virus did not destroy TG 
c
re
tive at blocking the spread of HSV-1 following a reactivation event. To further support 
the concept that IFNγ can directly block HSV-1 reactivation from latency in neurons, day 35 TG 
cells were prepared and depleted of CD45+ (bone marrow-derived) cells. Cultures were prepared 
and treated with ACV for 4 days followed by addition of medium alone or medium 
supplemented with rIFNγ. As shown in Figure 31, rIFNγ significantly delayed and red
 reactivation from latency in TG cultures lacking any detectable CD45+ cells (P < 0.001). 
Taken together, these data suggest that IFNγ can act directly on latently infected neurons to 
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 inhibit HSV-1 reactivation from latency, but it can also augment a protective response that 
appears to be mediated primarily by CD8+ T cells. 
4.5.2. Role of Perforin in Preventing HSV-1 Reactivation from Latency 
 We clearly established the important role of IFNγ in blocking HSV-1 reactivation in ex 
vivo TG cultures (Section. 4.5.1), next we wished to determine what role the lytic machinery of 
CD8+ T cells plays in preventing HSV-1 reactivation.  Our studies have demonstrated that CD8+ 
T cells can prevent reactivation without eliminating the reservoir of all the neurons harboring 
latent HSV-1.  However we cannot rule out the possibility that certain neurons harboring several 
copies of latent HSV-1 could be destroyed by perforin mediated mechanisms.  Moreover studies 
in our laboratory have confirmed that CD8+ T cells are more efficient than IFNγ alone at 
blocking HSV reactivation, suggesting an IFNγ independent mechanism.  In addition two recent 
studies have implicated the importance of perforin and granzymes in controlling early HSV-1 
replication in neurons (159,133).   
 Thus, to determine a role of perforin in maintaining HSV-1 latency, TGs from C57BL/6 
and perforin knock out mice 14 days after corneal infection were excised and single cell 
ivated compared to 
 
 
suspensions were cultured in medium alone. 100% of the PfP cultures react
25% of the WT cultures (Figure 32). To determine if CD8+ T cells were responsible for this 
protection, TGs were excised from C57BL/6 and perforin knock out (PfP) mice 14 days after 
corneal infection and single cell suspensions were cultured in medium alone or medium 
containing anti-CD8 mAb.   
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n important role in preventing HSV-1 reactivation.  TGs were 
excised 14 days after corneal infection from C57BL/6 (WT; n=8) and perforin KO (PfP; n=8) 
mice. Single cell suspensions were prepared and cultured (1TG/well) in medium alone. Culture 
supernatant were sampled every other day and assayed for infectious HSV-1 by plaque assay. 
00% of the PfP cultures reactivated compared to 25% of the WT cultures (Figure 33).  The 
rotection in WT cultures was mediated by the endogenous CD8+ T cells present in the TG at the 
me of excision since addition of anti-CD8 mAb resulted in loss of protection.  These data 
uggest that early after the establishment of latency (Day 14 PI) CD8+ T cells need perforin to 
 
edium alone.  
Since PfP mice secrete c  in PfP cultures that did 
echanisms are 
important in
Addition of anti-FasL mAb to latently infected TG cultures did not significantly affect 
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Figure 32: Perforin plays a
 
 
1
p
ti
s
protect ex vivo TG cultures from HSV-1 reactivation.  Interestingly PfP cultures that received
anti-CD8 mAb showed accelerated reactivation compared to PfP cultures in m
opious amounts of IFNγ, the delayed reactivation
not receive anti-CD8 mAb suggests lytic and non-lytic (IFNγ secretion) m
 blocking HSV-1 reactivation early during latency. 
reactivation frequency (data not shown). These data suggest that of the two cytolytic mechanisms 
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 used by CD8+ T cells to fight viral infections, only perforin mediated mechanism(s) is important 
in maintaining HSV-1 in a latent state.   
Figure +
reactiv
 
In the experiments with C57BL/6 mice we observed spontaneous reactivation in a small 
number of TG cultures.  In order to ensure the establishment of stable latency in all neurons after 
excision and derivation of single cell suspensions of TG we used the anti-herpetic drug ACV as 
in the previous section.  TGs from C57BL/6 and perforin knock out mice 14 days after corneal 
infection were excised and single cell suspensions were cultured as indicated in Figure 34.  Even 
after 4 day treatment with ACV, 100% of PfP cultures reactivated compared to 20% of WT 
cultures at day 10 after culture initiation.  The addition of anti-IFNγ mAb in PfP cultures resulted 
in accelerated reactivation frequency, moreover addition of rIFNγ reduced reactivation rate even 
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 33: CD8  T cells in Day 14 TG from perforin KO mice cannot block HSV-1 
ation from latency. TGs were excised 14 days after corneal infection from C57BL/6 (WT) 
and perforin KO (PfP) mice. Single cell suspensions were prepared and cultured (1TG/well) as 
indicated, for each group n=5. Both WT and PfP cultures received 100 µg/ml of anti-mouse 
CD8α or control mAb on the day of culture initiation (d 0).  Culture supernatant were sampled 
every other day and assayed for infectious HSV-1 by plaque assay. 
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 in PfP culutures, again suggesting the importance of IFNγ along with perforin in protecting TG 
cultures SV-1 reactivation at 14 days PI.   
 or anti-IFNγ (20 
/ml). For all groups n=8.  Culture supernatant were sampled every other day and assayed for 
fectious HSV-1 by plaque assay. 
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Figure 34: Perforin is required for efficient protection from HSV-1 reactivation in latent ex 
vivo TG cultures. TGs were excised 14 days after corneal infection from C57BL/6 (WT) and 
perforin KO (PfP) mice. Single cell suspensions were prepared and cultured (1TG/well) as 
indicated.  TG cell cultures were treated with ACV (50 µg/ml) for 4 days, rinsed and then 
incubated for an additional 10 days in medium alone or rIFNγ (1000 U/ml)
µg
in
 The data in the above 3 figures clearly established that perforin mediated mechanisms are 
important in protecting ex vivo TG cultures from HSV-1 reactivation early (Day 14 PI) during 
the latent stage of infection, although, the possibility of a non-cytotoxic mechanism involving 
selective utilization of GrA rather than GrB cannot be ruled out.  To investigate the role of 
perforin in protecting latently infected TG cultures at 34 days PI, TG single cell suspension were 
prepared and cultured as described above.   Interestingly PfP cultures reactivated sooner and with 
higher reactivation frequency compared to WT cultures, however the difference between the two 
groups at 34 days PI was not as significant as at day 14 PI (Figure 35). In addition supplementing 
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mechanisms that may exist in PfP mice, since there is evidence that PfP mice secrete more IFNγ 
res with rIFNγ greatly reduced the reactivation frequency of both PfP and WT cultures, 
suggesting that at 34 days PI the requirement of perforin to prevent HSV-1 rea
reduced compared to 14 days PI.  At 34 days after HSV-1 corneal infection non-cytolytic 
s such as IFNγ secretion appear to be essential for maintaining latency.  It should be 
 this particular experiment over all reactivation frequency of TG cultures was lower 
ximum reactivation percentage) compared to previous experiments where m
reactivation percentage was close to 100%.   
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Figure 35: At 34 Days PI perforin mediated mechanisms are not as important in blocking 
HSV-1 reactivation. TGs were excised 34 days after corneal infection from C57BL/6 (WT) and 
perforin KO (PfP) mice. Single cell suspensions were prepared and cultured (1TG/well) as 
indicated.  TG cell cultures were treated with ACV (50 µg/ml) for 4 days, rinsed and then 
incubated for an additional 10 days in medium alone or rIFNγ (1000 U/ml).  For all groups 
n=10.  Culture supernatant were sampled every other day and assayed for infectious HSV-1 by 
plaque assay. 
 
 At 34 days PI experiments with C57BL/6 and PfP mice (Figure 35) show that IFNγ 
secretion presumably by CD8  T cells in ex vivo latent TG cultures was necessary to prevent 
reactivation.  We have shown that IFNγ can block HSV-1 reactivation in ex vivo TG cultures 
derived from Balb/C mice (Section 4.5.1).  We were concerned about the compensatory 
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 that WT mice after viral infections (160)  Therefore supernatant fluids from WT and PfP cultures 
were tested for IFNγ by ELISA (Figure 36).  IFNγ production in protected PfP and WT TG 
cultures (medium alone) was identical, however in cultures that reactivated, IFNγ content in PfP 
cultures was greater compared to WT (data not shown).  IFNγ production peaked around 8 days 
after culture initiation but declined steadily thereafter.  Although IFNγ production in WT and PfP 
cultures was identical at 8 days, the reactivation frequency was higher in PfP compared to WT 
e indicated time points after culture initiation were combined and tested for IFNγ 
ontent by ELISA.  TG cell cultures were treated with ACV (50 µg/ml) for 4 days, rinsed and then 
cubated for an additional 10 days in medium alone or anti-CD8 mAb (100 µg/ml). 
+
T cells given that addition of anti-CD8 mAb completely abrogated the production of IFNγ in 
cultures at the same time (Compare Figure 36 and 35).   
0 2 4 6 8 10 12 14
0
500
1000
1500
2000
W/T α-CD8
W/T med alone
PfP α-CD8
PfP med alone
Days in Culture
IF
N
γ  (
pg
/m
l)
Figure 36: IFNγ production in PfP and WT cultures day 34 PI.  At the indicated times, 
supernatant fluids from the protected cultures (WT med alone and PfP med alone) described in 
Figure 35 at th
c
in
  
 
Data in Figure 36 also confirms that the main source of IFNγ in the WT and PfP cultures is CD8  
both types of cultures.    
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 4.6. Role of IL-2 and IL-15 in modulating effector and memory CD8+ T cell responses in 
Background and Rationale: 
 In response to viral infection, antigen specific effector CD8
a latent viral infection 
 
 
 where they are subsequently retained as 
effector memory cells (81,161).  There are myriad of factors that can contribute to the migration 
and m
(ii) chem
 ce there is a substantial 
inf  T cells was present in the 
pool of CD8  and ex vivo 
 specific CD8+ T cells.  These data indicate that the HSV-1 specific CD8+ T cells present in 
the TG 30+ days post infection are memory cells belonging to the effector memory T cell 
population.   
The CD8  T cell response observed in lymphoid organs of mice infected with LCMV and 
vesicular stomatitis virus (VSV) (77,78,81) is characterized by: (i) initiation of the immune 
response; (ii) clonal expansion of viral specific CD8+ T cells; (iii) a substantial reduction of 
that develops in the TG after HSV-1 corneal infection follows a similar course, with the 
s can be readily detected in the TG, albeit in a latent state; and (ii) 
+ T cells migrate to non-
lymphoid tissues irrespective of the presence of antigen,
aintenance of memory T cells in non-lymphoid tissues including: (i) antigen persistence; 
okines and cell adhesion molecules; and (iii) cytokines.   
We have shown that after HSV-1 corneal infection of mi
iltration of CD8+ T cells in the TG.  The highest density of CD8+
ipsilateral ganglion 8 days p.i., the population declined through day 34 p.i., and then a constant 
+ T cells was maintained for the life of the animal (33).  Both in situ
tetramer staining revealed that 60% of the CD8+ T cells that were retained in the ganglion were 
specific for the immunodominant epitope (gB498-505) on the γ1 gene product gB.  All CD8+ T 
cells were CD44hi and surprisingly 80% expressed CD69. CD69 expression was greater among 
gB
+
effector CD8+ T cells; and (iv) formation of a stable memory pool.  The CD8+ T cell response 
following exception: (i) viru
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 virtually all the memory CD8+ T cells in the TG retain CD69 expression, and exhibit TCR 
polarization to junctions with neuron cell bodies.  Together these findings suggest preferential 
TCR stimulation through direct contact with infected neurons.  These observations beg the 
question: what are the mechanisms that mediate the infiltration, expansion and retention of 
effector and memory CD8  T cells in the TG and lymphoid organs?  Cytokines such as IL-2 and 
IL-15 participate in the differentiation of naïve CD8  T cells into effector and subsequently 
memory CD8  T cells. IL-2 and IL-15 belong to family of cytokines that use the common 
cytokine receptor γ chain (γc-chain).  IL-15 and IL-2 receptors are comprised of three 
components, the high affinity receptor (α-chain), the relatively low affinity receptor CD122 (β-
chain) and the γc chain.  The α-chain chain for each cytokine is unique where as the β and γc-
-/- and IL-2R-/- mice following antigenic challenge, and these mice actually 
develo
+
+ +
+
-/- -/- +
+
+
+
+
+
chains are shared (93).  While the binding of each cytokine is controlled by the α and β-chain, 
signal transduction is mediated by β and γc chains. 
Based primarily on in vitro studies, IL-2 thought to be an essential growth factor for T 
lymphocytes following antigenic stimulation (162).  However, cell expansion appears to be 
normal in  IL-2
p severe lymphoproliferative diseases (163,164,165).  There are conflicting findings 
regarding the role of IL-2 in CD8  T cell expansion and in the generation and maintenance of 
CD8  T cell memory.  In some studies IL-2 was essential for initial CD8  T cell expansion 
(166,97), where as other studies have dismissed the role of IL-2 in CD8  T cell proliferation 
(163, 167). Using adoptive transfer of IL-2  and IL-2R CD8  T cells, D’Souza et al. 
demonstrated that IL-2 was required for sustained expansion but not for the initiation of CD8  T 
cell cycling (99).  Therapeutic use of IL-2 was recently tested at different stages of CD8  T cell 
response after LCMV infection (168).  Interestingly, rIL-2 administration during the expansion 
79 
 phase (1-7 days PI) accelerated the contraction of antigen specific CD8+ T cells but did not 
influence the extent of initial T cell expansion or the size of the T cell memory pool.  In contrast, 
IL-2 increased the size of the memory pool when administered during the contraction and 
memory phases.  In contrast, in vivo treatment with anti-IL2 antibody was beneficial to memory 
CD8+ T cells, demonstrating negative effects of IL-2 on memory cells (95).  
 Another member of the γc family of cytokines is IL-15, which has many important 
immunological properties.  Studies with IL-15-/- and IL-15R-/- mice have clearly implicated IL-15 
as essential for memory CD8+ T cell maintenance and survival (100,169,170).  IL-15 mediates 
low-level memory CD8+ T cell division; thus, preventing the attrition of the memory T cell pool 
long after virus is cleared from the body.  The primary sources of IL-15 are macrophages, 
monocytes and dendritic cells, in addition IL-15 mRNA is found in many non-lymphoid tissues.  
Besides being a T cell growth factor recent human studies have implicated IL-15 as a potent 
chemoattractant for T cells as well as an effective inducer of antibody production by B cells 
(171,172).  The beneficial properties of IL-15 on antigen specific memory CD8+ T cells is well 
established, however its role in CD8+ T cell expansion early after a viral infection is not well 
understood.  The role of IL-15 in primary CD8+ T cell expansion has been dismissed, given that 
mice lacking IL-15-Rα or IL15 were able to mount efficient primary CD8+ T cell response to 
acute viral infections (173,169,100),  although, another study implicated IL-15 in early 
expansion of alloreactive CD8+ T cells in vivo (174).   
 Each of these cytokines may have a distinct function at different stages of a CD8+ T cell 
response to viral infections. At some stage IL-2 and IL-15 may work in concert while in others 
their roles may contrast (174,95).  The role of IL-2 and IL-15 in modulating CD8+ T cell 
responses to persistent and latent viral infection in non-lymphoid tissues in vivo is poorly 
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 understood.  Unlike the majority of the viral mouse models that use acute systemic viral 
infections to study IL-2 and IL-15 functions, HSV-1 is a localized infection, where the virus 
establishes latency in sensory ganglia and is never cleared from the body.  In the next set of 
udies
independent CD8  T cells in the LN 
 Foot pad infection with HSV-1 has revealed that the magnitude of CD8  T cells response 
in draining LN is highest at 5 days PI (124).  To examine the effect of IL-15 on T cell expansion 
in LN after HSV-1 corneal infection, WT and IL-15 mice were infected with HSV-1 and 
sacrificed at day 5.  Draining submandibular LN were extracted and single cell suspensions were 
stained for CD8, CD4 and gB specific TCR.   CD8  T cell expansion in LN was dramatically 
reduced in IL-15  mice, however CD4  T cell expansion was not affected by the lack of IL-15 
(Figure 37A).  Similarly, gB specific CD8  T cells were also reduced in IL-15  mice (Figure 
37B).  These data suggest that IL-15 is required for early expansion of antigen specific and non 
specific CD8  T cells, suggesting a role of IL-15 in bystander activation of naïve or memory 
CD8  T cells. 
 
 
 
 
st  we wished to determine how IL-2 and IL-15 contribute in shaping CD8+ T cell response 
at different stages of HSV-1 infection and whether the presence of latent virus influences the 
functions of these cytokines.  
 
Results: 
4.6.1. IL-15 but not IL-2 is essential for initial expansion of viral specific and antigen 
+
 
+
-/- 
+
-/- +
+ -/-
+
+
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Figure 37: Primary expansion of lymphoid CD8+ T cells 5 days after HSV-1 corneal infection 
is dependent on IL-15.  LN cells from WT or IL-15  mice 5 days PI were stained for CD8, CD4 
(A) or gB specific TCR (B).  Mean percent ± SEM (n=3) **P=0.0097.  A non parametric Student 
t test was perfo
-/-
rmed to determine the statistical significance. 
  
.6.2. IL-15 and IL-2 are both essential for regulating primary T cell responses in the TG: 
Our previous studies have shown that CD8+ T cells reach their peak density at 8 days 
fter corneal infection (Figure 12), therefore to determine the period of greatest CD8+ T cell 
xpansion we compared the magnitude of CD8+ T cell proliferation in the TG between 6 and 8 
days PI.  Figure 38 shows that number of CD8+ T cells in WT mice increase more than 7 fold 
between day 6 and 8 after corneal infection.  CD8+ T cell  
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Figure 38: Number  by 7 fold between 6 and 8 days PI.  
Single cell suspensions of TG obtained from C57BL/6 (WT; n=3) and IL-15-/- (IL-15-KO; n=3) 
mice 6 and 8 days (WT; n=6, and IL-15-KO; n=9) after corneal infection were stained for CD8.  
Total number of CD8+ T cells in each TG was determined by running the entire single cell 
suspension of each TG through the flow cytometer.  Error bars indicate mean percent ± SEM.   
 
 
infiltrate ys after corneal infection in WT and IL-15-/- mice was similar; however the 
increase i ber between day 6 and 8 was severely compromised in IL-15-/- mice. 
 To determine if nic primary T cell responses in vivo, WT 
nd IL-15-/- mice were either untreated or treated with 1mg anti-IL-2 mAb at day 6 after corneal 
D4, CD45 and MHC class-I dimers 
+
agnit + +
-/-
+ +
periments were left untreated.  
 
 
of ganglionic CD8+ T cells increase
 at 6 da
n CD8+ T cell num
IL-2 and IL-15 regulate ganglio
a
infection and sacrificed at 8 days PI.  TGs from each mouse in the indicated groups were 
extracted and single cell suspensions were stained for CD8, C
were used to identify HSV-1 gB-specific CD8  T cells. Compared to WT untreated mice the 
m ude of CD8  and CD4  T cell responses in the TG 8 days after corneal infection was 
significantly compromised in IL-15  mice as well as anit-IL-2 treated mice (Figure 39A).  
Untreated mice and mice treated with isotype matched control antibody (for anti-IL-2 mAb) 
showed no difference in CD8  or CD4  T cell sponses in the TG or LN (data not shown). 
Therefore as a control, a subset of mice in all subsequent ex
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Figure 39: IL-15 and IL-2 are both required for adequate T cell responses in the TG at 8 days 
with anti-IL-2 mAb (1mg) IP (WT Anti IL2; n=9, IL15 Anti-IL2; n=9), at day 6 PI. Single-cell 
stained for CD45, CD4 and CD8 (A) or CD45, CD8 and gB-specific TCR (B).  For each reaction 
were collected. Forward and side scatter gates were set to encompass the CD45 population (A), 
determined by one way ANOVA (non-parametric) analysis with Bonferroni post test comparing 
above graph represents combined data of 3 independent experiments. 
e the 
ffect of IL-15 and IL-2 on antigen specific CD8+ T cells.  As shown in Figure 39B gB specific 
*
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PI. C57BL/6 or IL-15-/- mice mice were either untreated (WT; n=6, IL15 KO; n=9) or treated 
suspensions of TG obtained from mice 8 days after HSV-1 corneal infection were simultaneously 
single cell suspensions from every individual TG was stained and all the events from each TG 
or CD8+ population (B).  Significance of differences between WT and all indicated groups were 
all groups together. *P<0.01 and **P<0.001, error bars indicate mean percent ± SEM.  The 
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 CD8+ T cells were reduced by more than 70% in IL-15-/- and in anti-IL-2 treated mice.  
Interestingly, e magnitude of viral specific CD8+ cell response was 
consistently greater in IL-15-/- mice treated with anti-IL-2 antibody (Figure 39B; compare IL-15-
KO Anti-IL-2 group  Anti-IL-2 and IL-15-KO groups), suggesting an additive effect of 
blocking both cytokines together as opposed to individually in vivo.  Thus, data in Figure 39 
indicate that IL-2 and IL-15 are important in mediating primary viral specific as well as antigen 
independent CD8+ T cell responses in latently infected non-lymphoid organs such as the sensory 
ganglion. 
 
4.6.3. IL15 but not IL2 is required for primary CD8+ T cell response in LN at 8 days after 
HSV-1 corneal infection 
 
 To determine if IL-2 and IL-15 influence primary lymphoid CD8+ T cell response in vivo, 
WT and IL-15-/- mice were either left untreated or treated with 1mg anti-IL-2 mAb at day 6 after 
corneal infection and sacrificed at 8 days PI.  Single cell suspension of LN were stained for CD8 
and gB specific TCR.   Number of CD8+ T cells in the lymph nodes was dramatically reduced in 
emory lymphoid CD8  T cells as well as the early expansion of antigen 
specific lymphoid CD8+ T cells after HSV-1 corneal infection.  In all three experimental groups 
of mice
nution in th the dimi
with WT
IL-15-/- mice but the number of CD8+ T cells in anti IL-2 treated mice was similar to the control 
(Figure 40A).  The number of antigen specific CD8+ T cells in the lymph nodes was also 
negatively affected by the lack of IL-15 (Figure 40B); however the reduction was not as 
impressive as the reduction in total number of antigen independent CD8+ T cells. The data in 
Figure 40 and 37 suggest the requirement of IL-15 in the bystander activation of antigen 
+independent naïve or m
 the expansion of CD4+ T cells in the LN was not affected (data not shown), suggesting 
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 neither IL-15 nor IL-2 regulate early lymphoid CD4+ T cell responses of mice infected with 
HSV.  
 
 
Figure 40: IL15 but not IL2 is
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 Judging from the data acquired from experiments done with LN and TG, it appears that 
IL-15 and IL-2 can exert their effects on T cells differentially depending on the location of T 
ells in the body.   
 
4.6.4.  T cells 
 
 the reduction in CD8+ T cell numbers in th  PI was 
the result of a lack of proliferation, mice in each group were treated with BrdU at 6 and 7 Days 
PI.  Flow cytom ed at 8 days PI (Figure 41A).  Incorporation of BrdU 
in CD8+ s n d cation of cell division during the 
short 48 hour period. In IL-15-/- mice only 50% of the CD8+ T cells
day 6 and 8 after HSV-1 corneal infection, which correlated well w bsolute 
number of ls in the LNs (Figure 41A.)  As expected blocking IL-2 in WT mice 
showed no effect as the percentage of CD8+ T cells that were BrdU positive was similar to WT 
untreated mice.  The percentag + T cells that incorporated BrdU between 
ay 6 and 8 PI was also reduced significantly in IL-15-/- mice (Figure 41B).   As anticipated from 
c
IL-15 drives optimal proliferation of antiviral and antigen independent CD8+
in the LN 
To confirm that e lymph nodes at D8
etric analysis was perform
 T cell  betwee ay 6 and 8 PI was considered an indi
 incorporated BrdU between 
ith the reduction in a
CD8+ T cel
e of viral specific CD8
d
data in Figure 40 we did not observe any greater reduction in BrdU positive CD8+ T cells in IL-
15-/- mice treated with anti-IL-2 mAb compared to untreated IL-15-/- mice, confirming that IL-15 
and not IL-2 drives the turnover of both viral specific and antigen independent CD8+ T cells in 
LN early after HSV-1 corneal infection. 
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 Figure 41: The reduction 
IP at day 6 and 7 after cor
days after HSV-1 corneal 
day 6 and 8 PI (A), and pe
determined by one way AN
n=3. 
 
 
*
A 
B 
a result of poor proliferat
treated with 1mg anti-IL-2 
incorporated BrdU. Percen
day 6 and 8 PI (B). Sign
all groups together. *P<0.
  
 
*
0 
1 
2 
WT
IL-15KO 
WT anti-IL2 
IL-15KO anti-IL2 
%BrdU + CD8 T cells 
*
*
0 
10 
20 
30 
40 
50 
60 
70 
WT Anti IL2 
IL15 KO 
IL15 KO Anti IL2 
%BrdU
WT**in number of lymphoid CD8  T cells in IL15-KO mice at 8 days PI is 
neal infection. C57BL/6 and IL-15-/- mice were either left untreated or 
infection were simultaneously stained for CD8, gB-specific TCR and 
rcentage of gB-specific CD8  T cells that incorporated BrdU between 
OVA (non-parametric) analysis with Bonferroni post test comparing 
 indicate mean percent ± SEM. For all indicated groups 
+
ion.  Mice in each indicated groups were administered 1mg of BrdU 
mAb at day 6 PI.   Single-cell suspensions of LN obtained from mice 8 
tage of total number of CD8+ T cells that incorporated BrdU between 
+
ificance of differences between WT and all indicated groups were 
01, error bars
 gB specific CD8 T cells+ +
88 
 4.6.5. +
 
15-/- mi feration (as seen in 
the LN); mice in each experimental group were gi  
and sacrificed at 8 days after HSV-1 corneal infection.  Ganglionic CD8+ T cells that 
incorporated BrdU were considered to have recently divided between days 6 and 8 PI; however 
the possibility that some CD8+ T cells may have divided outside of the TG (i.e. LN) during the 
48 hr tre  cannot be com ly eliminated.   
 
 
 
 
 
 
 42) on were simultaneously stained for CD8, gB-
ecific TCR and incorporated BrdU.  Total number of CD8+ T cells that were BrdU positive 
rdU+CD8+), gB-dimer positive CD8 T cells that were BrdU positive (BrdU+CD8+gB+), and 
that were BrdU positive (BrdU+CD8+gB-) are shown. 
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Figure 42: The dysregulation in the level of CD8+ T cells response in the TG was not due to a 
decrease in proliferation. BrdU incorporation in ganglionic CD8+ T cells was determined in the 
same mice in Figure 41. Single-cell suspensions of TG obtained from mice (the same mice as in 
figure
sp
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 As shown in Figure  42 the lack of IL-2 or IL-15 did not affect the proliferation of gB-
imer+
+
+ ngly more 
than 50% of gB-dimer- CD8+ T cells incorporated BrdU, suggesting an unusually high turnover 
 
subdom + T cell (data not shown) in any groups of mice 
suggesting the likelihood of substantial bystander activation of CD8+ T cell in the TG. 
 
4.6.6. o IL-15 and IL-2 mediate lymphoid or non-lymphoid CD8+ T cell survival early 
after HSV-1 corneal infection? 
 
ince IL-15 and IL-2 can promote T cell survival, we wished to determine if the 
reduction in primary CD8+ T cell response in the TG of IL-15-/- mice and mice treated with anti-
L-2 mAb was a result of increased cell death.  Therefore we tested the apoptotic potential of 
V positive 
dicating no increase in cell death in mice lacking IL-15 or IL-2 (Figure 43).  Cell death in viral 
specific CD8+ T cells was also similar in all groups of mice tested (data not shown).  However, at 
d  or gB-dimer- CD8+ T cells suggesting neither of the cytokines drive CD8+ T cell turnover 
during the lytic phase of HSV-1 infection in sensory ganglion.  The reduction in CD8  T cell 
expansion between day 6 and 8 PI in the TG of virally infected IL-15-/- mice could be at the level 
of priming in the LN as CD8+ T cell proliferation in the LN of IL-15-/- mice was compromised. 
However, the reduction in CD8+ T cell expansion in anti-IL2 treated mice still remains 
inexplicable.  Notably the highest percentage of BrdU incorporation was seen in gB-specific 
CD8  T cells indicating preferential proliferation of viral specific cells but surprisi
of apparently antigen independent CD8+ T cells in the TG.  We did not observe proliferation of
inant population of RR1 specific CD8
D
 
S
I
ganglionic CD8+ T cells at 8 days PI in vivo by using the annexin-V assay.  One of the earliest 
events in a cell undergoing apoptosis is the exposure of phosphatidylserine (PS) on the surface of 
the cell, annexin-V binds to PS with high affinity and can be used to identify early apoptotic cells 
(175).  More than 40% of ganglionic CD8+ T cells in all groups of mice were annexin-
in
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 8 days 
+ 1 corneal 
mice was 
etermined by annexin-V binding.   
  
I.  
To our surprise percentage of CD8  T cells that were annexin-V positive was significantly higher 
in IL-1
PI it may already be too late to detect early apoptotic cells in the TG, hence the assay will 
have to be repeated earlier i.e. 6 or 7 days after HSV-1 corneal infection.  These data show that 
blocking IL-2 neither compromised primary CD8+ T cell proliferation nor increased cell death in 
the TG of mice infected with HSV-1. 
 
Figure 43: Apoptotic potential of CD8  T cells in the TG at 8 days after HSV-
infection.  Apoptosis of ganglionic CD8+ T cells from the indicated groups of 
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We next examined annexin-V binding on CD8+ T cells in the LNs of mice at 8 days P
+
5-/- mice that received anti-IL2 antibody compared to all the other 3 groups of mice 
(Figure 44B). A similar pattern of apoptosis was detected in gB specific CD8+ T cells (data not 
shown).  Lymphoid CD8+ T cell apoptosis was elevated in all groups of mice compared to WT 
untreated mice.  The apoptosis data in Figure 44 do not however correlate well with the absolute 
number of CD8+ T cells present in the LN at 8 days PI, for instance we did not observe any 
difference in lymphoid CD8+ T cell numbers between anti-IL2 treated and untreated IL-15-/- 
mice (Figure 41) 
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 4.6.7. IL-15 is Ess ial for the Formation of Effector and Central Memory CD8+ T cell 
Pool after HSV-1 Corneal Infection 
 
IL-15 has been shown to regulate homeostatic proliferation of memory CD8+ T cells in 
lymphoid organs (169,100), on the other hand IL-2 has been determined to be a negative (95) as 
well as a positive regulator of lymphoid memory CD8+ T cells (168).  HSV-1 infection provides 
us with a unique model to study how cytokines influence lymphoid and extra-lymphoid memory 
T cells.  It would be interesting to determine ho resence of latent virus as well as 
the possibility of infrequent antigen presentation in e TG (2 t the ability of IL-2 and 
IL-15 to regulate ce  and effector HSV-1 specific memo  c lls.  To this end, we 
repeated the above experiments at 65 days after HSV-1 corneal infection.  WT and IL-15-/- mice 
were either treated with control or anti-IL-2 antibody at 6 days and sacrificed at 65 days after 
SV-1 corneal infection. The effector/memory CD8+ T cell pool in the TG was considerably 
 specific splenic memory CD8  T cell pool 
-/-
 
ent
w would the p
th 9,33) affec
ry CD8+ T entral
H
smaller in control as well as anti-IL-2 antibody treated IL-15-/- mice compared to both groups of 
WT mice (Figure 45).  Notably, the memory CD8+ T cell pool in the TG of anti-IL-2 treated WT 
mice was similar to control WT mice suggesting that effector memory CD8+ T cell pool was not 
affected  even though primary CD8+ T cell response (Day 8 PI; Figure 39) in the TG of anti-IL-2 
treated WT mice was markedly compromised.  Viral +
(Central memory cells) was also noticeably reduced in IL-15  mice.   
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Figure 45: IL-15 is required for the maintenance of viral specific memory CD8
 
anti-IL-2) at 6 days PI.  Mice were sacrificed at 65 days PI, Single-cell suspensions of TG and 
  
 CD8 T cells in the TG of 
-15-/- mice or anti-IL-2 treated mice at any time points after the establishment of latency (data 
not shown). 
 
+ T cells.  
C57BL6 mice were treated with 1mg control (WT) or 1mg anti-IL-2 antibody (WT anti-IL-2).  IL-
15-/- mice were were treated with 1mg control (IL-15-KO) or 1mg anti-IL-2 antibody (IL-15-KO 
spleen were stained for CD8, and gB-specific TCR.  The data shows total of number of gB-
specific CD8+ T cells cells per TG or 1.5 x 106 spleen cells. Error bars indicate mean percent ± 
SEM. For all indicated groups n=3. 
 
In Figure 14 we demonstrated that more than 80% of the CD8+ T cells retained in the TG 
as late as 84 days PI expressed the early activation marker CD69.  There have been several 
recent reports implicating the role of IL-15 in upregulating CD69 on T cells and B cells (176-
180), yet we did not observe any reduction in the percentage of CD69+
IL
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6 days PI.  Mice were sacrificed at 65 days PI, Single-cell suspensions of TG and 
leen were stained for CD4, and CD45.  The data shows total of number of CD4+ T cells cells 
er TG (A) or 1.5 x 106 spleen cells (B). Error bars indicate mean percent ± SEM. For all 
indicated groups n=3. 
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C57BL6 mice were treated with 1mg control (WT) or 1mg anti-IL-2 antibody (WT anti-IL-2).  IL-
15  mice we
anti-IL-2) at 
sp
p
95 
 We also determined if CD4+ T cell responses in the TG as well as in secondary lymphoid 
organs were affected by the lack of IL-15 or (and) IL-2 at 65 days after HSV-1 corneal infection.  
Number of CD4+ T cells  in the TG at 65 days PI was markedly reduced in IL-15-/- mice 
(Figure 46A) compare to WT controls, where as number of CD4+ T cells in the spleen was 
unaffected by the lack of IL-2 or IL-15 (Figure. 46B).  This result is contrary to other studies that 
have found no evidence that proliferation or survival of CD4+ T cells is influenced by IL-15 
(102,170,181).  However these studies only examined the effect of IL-15 on lymphoid and 
splenic CD4+ T cells.  Therefore contrary to lymphoid CD4+ T cells, effector/memory CD4+ T 
cells (those retained in the TG) depend on IL-15 for their prolifera nd (or) survival after 
HSV-1 infection.   
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5.1. HSV-1 Specific Memory CD8  T cells are selectively Retained in Latently Infected 
Our current findings challenge the notion that HSV-1 latent infection in sensory ganglia 
host immune system.  Instead, we establish that a dynamic HSV-specific CD8  T cell response is 
notion that HSV-specific CD8+ T cells are persistently stimulated 
ithin the latently infected ganglion.  First, at least 60% of the CD8+ T cells in the latently 
fected TG were HSV-specific as demonstrated by binding to the gB498-505 tetramer ex vivo.  
econd, during the early stages of CD8+ T cell infiltration into the infected TG, a time when 
virus replication was subsiding and latency was being established in sensory neurons, few CD8+ 
T cells expressed the early activation marker CD69.  However, CD69 expression on ganglion-
derived CD8+ T cells gradually increased through day 34 p.i., long after latency was uniformly 
established in the TG.  Moreover, CD69 expression was maintained for at least 84 days p.i.  
Third, the variable size and level of CD8 expression on the CD8+ T cell population that initially 
infiltrated the TG (day 8 –14 p.i.) gradually gave way to a more homogeneous, large, CD8hi 
population during latency (day 34 – 84 pi), indicative of a shift to a more uniformly activated 
CD8+ T cell population.  Finally, in situ staining of latently infected TG with the gB498-505 
tetramer revealed TCR polarization on many CD8+ T cells towards the T cell-neuron junction. 
This latter observation is suggestive of TCR aggregation in lipid rafts, as occurs during T cell 
ISCUSSION 
The contents of sections 5.1 and 5.2 have been modified from articles (33,73).  Copyright 
permission is on file. 
+
TG and can Regulate Viral Gene Expression. 
 
represents a quiescent state wherein a lack of viral gene expression conceals the virus from the 
+
maintained in the TG for at least 75 days after HSV-1 latency is uniformly established.  Several 
lines of evidence support the 
w
in
S
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 acti ation (182). Althv ough there have been a few previous reports of in situ tetramer staining 
(143
gether, these findings suggest that HSV gB-specific memory CD8+ T cells 
are maintained in an activated state through a direct interaction with latently infected neurons 
of the viral genome including the γ1 gene gB.   
+
,144), we believe this is the first report of such staining following infection in a non-
transgenic model.  To
that persistently or episodically express a portion 
 We also noted a significant increase from 14 – 34 days p.i. in the proportion of ganglion-
derived gB498-505 tetramer positive CD8  T cells that produced IFN-γ in response to gB498-505 
peptide-pulsed target cells.  Their levels then remained constant through day 84 p.i.  However, it 
should be noted that the total number of CD8+ T cells in the TG dropped during the period of 14-
34 days p.i., so that the actual number of IFN-γ+, gB498-505 peptide-specific CD8+ T cells 
remained relatively constant.  Thus, the increased proportion of IFN-γ-secreting cells could 
reflect either selective retention of a small population of cells capable of producing IFN-γ in 
response to gB peptide at day 14, or expansion of IFN-γ+ CD8+ T cells in the TG through cell 
division or a functional change.  We tend to favor the theory that the number of IFN-γ-producing 
cells in the TG increases during latency, because we routinely detect significantly more IFN-γ 
production by one TG equivalent of day 34 TG than by one TG equivalent of day 14 TG in ex 
vivo cultures (data not shown).  Other viral infection models have demonstrated a similar 
enrichment for IFN-γ producing CD8+ T cells at sites of infection (148,183). Together these 
findings suggest that CD8+ T cells that are retained at a peripheral site of infection undergo an 
antigen-driven maturation process resulting in enhanced IFN-γ production.  Since IFN-γ can 
block HSV-1 reactivation from latency in sensory neurons, this functional shift would appear to 
produce a CD8+ T cell population that is ideally suited to the function of long-term protection 
with minimal tissue destruction.   
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  It was recently reported that IFN-γ and TNF-α expression persisted in TG that were 
latently infected with an HSV-1 mutant lacking viral thymidine kinase (Tk- HSV-1) (22).  Since 
Tk- HSV-1 mutants are unable to replicate their DNA in neurons, these findings suggest that 
maintenance of cytokine production occurred in the absence of viral DNA synthesis within the 
ganglion.  DNA synthesis is not only required for production of infectious virions, but is also 
+
+
+
 product would be expressed too late in the viral 
necessary for expression of the γ2 class of HSV-1 genes during a lytic infection.  In contrast, the 
α, β, and γ1 genes are expressed in the absence of viral DNA synthesis.  Thus, it is reasonable to 
speculate that HSV α, β, and γ1 genes may be expressed in latently infected neurons in the 
absence of viral DNA synthesis and γ2 gene expression. Our current studies clearly establish that 
a gB498-505 epitope-specific CD8+ T cell clone (2D5) can block HSV-1 reactivation from latency 
in ex vivo TG cultures derived from syngeneic C57BL/6 mice, but not from allogeneic Balb/c 
mice.  This result established that the protective response is MHC restricted, and thus involves 
TCR engagement by an MHC I/ gB498-505 peptide complex.  Although sensory neurons do not 
normally express detectable MHC, they do express MHC I during the lytic phase of HSV-1 
infection (139).  Thus a reactivation stimulus that overcomes repression of viral gene expression 
might result in concordant expression of MHC I, allowing rapid presentation of viral epitopes to 
CD8+ T cells. 
 We show that virtually 100% of HSV-1–specific CD8  T cells in the latently infected TG 
at 34 days p.i. recognized the gB498-505 epitope, and that all gB498-505 tetramer positive cells were 
CD69 .  A similar immunodominance of the gB498-505 epitope is seen during the inductive phase 
of the immune response to HSV-1 (124).It is somewhat surprising that a viral late gene product 
would be targeted by CD8  T cells, and that these T cells could block HSV-1 reactivation from 
latency.  One might predict that a viral late gene
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 lif le to elicit a CD8e cyc
f HSV-1 infected mice (32), or the addition of the gB498-505 epitope-specific CD8+ 
+ T cell response capable of blocking virion formation.  It is noteworthy, 
however, that although gB is a γ1 gene, CD8+ T cells specific for gB are activated very early after 
infection (127), and the gB498-505 epitope appears to be expressed on cells within hours of 
infection (128). 
 These observations suggest a “just in time” mechanism in which CD8+ T cells within the 
ganglion may only respond when the virus reaches the point in its life cycle where γ1 genes are 
expressed, immediately prior to replication of its DNA.  Such a mechanism would require a rapid 
response by the CD8+ T cells capable of shutting down further progression of the viral life cycle, 
possibly by inhibiting viral DNA synthesis.  Indeed, we show in ex vivo TG cultures that CD8+ T 
cells reactive to the γ1 gene product gB block expression of the γ2 gene gH.  The capacity of 
CD8+ T cells to provide such exquisite regulation of HSV-1 gene expression in vivo is suggested 
by their juxtaposition to neuron cell bodies in the ophthalmic branch of the latently infected TG, 
and their persistent stimulation by neurons as indicated by CD69 expression and polarization of 
their TCR towards the T cell-neuron junction.  
 Based on this and our previous studies, we propose that CD8+ T cells employ multiple 
mechanisms to block HSV-1 reactivation from latency.  The addition of CD8+ T cells from the 
lymph nodes o
T cell clone, 2D5 at the initiation of day 34 TG cultures completely blocked HSV-1 reactivation 
from latency. In contrast, the addition of IFNγ (1000 U/ml) to day 34 TG cultures had no effect 
on reactivation frequency, unless the cultures were first treated for four days with the 
antiherpetic drug acyclovir (73).  The addition of IFNγ to cultures within 24 hours of acyclovir 
removal effectively prevented HSV-1 reactivation from latency.  These findings suggest that 
IFN-γ can block HSV-1 reactivation only when present early in the reactivation process.  
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 Apparently during TG culture preparation some neurons exceed the window of opportunity for 
IFNγ protection, and require some other CD8+ T cell mechanism such as perforin/granzymes to 
block reactivation (Section. 4.5.2).  
 There is growing evidence that memory CD8+ T cells may reside in non-lymphoid tissues 
498-505 peptide -specific CD8+ T cells 
+
following viral infections (81,161).  In one study, CD8+ T cells were shown to reside in multiple 
tissues that did not appear to harbor viral genome or proteins, leading to the suggestion that 
memory CD8+ T cell retention might not be an antigen-driven process (81).  However, in that 
study the virus was administered intravenously, so the presence of very low levels of viral 
protein in multiple tissues could not be formally excluded.  Following HSV-1 corneal infection, 
CD8+ T cells were selectively retained in the ophthalmic branch of the ipisilateral TG, where the 
viral genome is readily detectable.  Moreover, while high levels of CD44 was consistently 
expressed on CD8+ T cells in the latently infected TG, CD69 expression actually increased 
during the first 34 days p.i., and was then maintained on 90% of CD8+ T cells through 84 days 
p.i.  Our findings are consistent with the notion that HSV gB
are retained in the latently infected TG in an activated, memory phenotype due to persistent low-
level antigenic stimulation.  The concept that functional T cell memory requires persistent 
antigen has been proposed and supported by experimental data (184,185,186,90).  Although 
CD69 expression has been observed on memory CD8+ T cells in tissues that appear to lack 
antigen (161,187), in one study CD69 expression diminished over time (161).  Combined with 
the observation that gB498-505 peptide -specific CD8+ memory T cells appear to primarily reside 
outside of the lymphoid organs following primary HSV-1 infection (188), our findings suggest 
that the latently infected TG could be a site of retention of HSV-specific CD8  effector memory 
T cells. 
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  There appears to be a dynamic balance between HSV-1 latency and reactivation 
involving a tripartite interaction among the virus, the host neuron, and the local immune 
components.  We propose that the capacity of latently infected neurons to repress viral and MHC 
5.2. How do CD8  T cells Prevent HSV-1 Reactivation? 
ormer exhibited dramatically reduced lytic function but maintained IFNγ production.  
gene expression may be frequently perturbed, permitting rapid processing and presentation of 
some viral gene products to surrounding CD8+ T cells.  The more frequent reactivation of HSV-1 
in human TG may reflect a less efficient CD8+ T cell response.  This would be consistent with 
the fact that the HSV-1 ICP47 protein binds more efficiently to human than to mouse TAPs, thus 
inhibiting the loading of antigenic peptides on human MHC I (189).  In neurons that express very 
little MHC I, ICP47 might delay the activation of resident CD8+ T cells long enough to permit 
some virion formation.  We propose that an appropriate vaccine targeting CD8+ T cells specific 
for viral proteins that are expressed during latency might prove highly efficacious in preventing 
recurrent herpetic disease.   
+
The nervous system is a preferred site of viral persistence. The susceptibility of neurons 
to persistent viral infections has been attributed to the fact that neurons are post-mitotic and poor 
targets for T-cell surveillance due to low expression of MHC molecules. On the other hand, there 
is growing evidence that T cells might play an important role in maintaining certain viruses in a 
persistent or latent state in the central or peripheral nervous system (136,190,148,183).  A recent 
study involving persistent mouse hepatitis virus infection of the central nervous system 
demonstrated that antigen-specific CD8+ T cells were retained for prolonged periods in the 
central nervous system (148). The CD8+ T cells that were retained in the brain after clearance of 
infectious virus were functionally distinct from those present during the acute phase of infection, 
in that the f
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 This shift in CD8+ T cell function might represent an adaptation designed to accommodate the 
changing needs of the tissue as the infection progresses from the acute to the latent or persistent 
stage. During the acute stage of infection both lytic and nonlytic mechanisms might be required 
to eliminate replicating virus in the infected tissue. In contrast, non- lytic, cytokine-mediated 
mechanisms might be sufficient to maintain the virus in a latent or persistent state, while 
avoiding unnecessary tissue destruction.  Using two different strains of mice we have provided 
clear evidence that CD8+ T cells are capable of preventing HSV-1 reactivation in sensory 
neurons (32,33).  Using ex vivo TG cultures derived from Balb/C mice we previously 
demonstrated that CD8+ T cells that were present in the TG 14 days after HSV-1 corneal 
infection could completely block HSV-1 reactivation from latency, however, the endogenous 
CD8+ T cells present in TG obtained 34 days PI infection delayed, but could not prevent, HSV-1 
reactivation.  HSV-1 reactivation was completely blocked in day 34 TG cultures when 
supplemented with exogenous CD8+ T cells obtained from draining lymph nodes 7 days after 
HSV-1 corneal infection +
the exogenous cells merely provided a critical density of HSV-reactive CD8+ T cells in the 
+
functional program than those retained in the ganglion during latency.  We have demonstrated 
+
+
Thus, in the latently infected TG, there is indeed a selective enrichment of gB-specific CD8+ T 
, moreover addition of 2D5 cells (gB-specific CD8  T cell clone) to day 
35 ex vivo cultures derived from C57BL/6 mice prevented HSV-1 reactivation.   It is not clear if 
culture, or if the CD8  T cells that are generated during acute infection possess a different 
that CD8  T cells retained in the TG at 35 days after HSV-1 corneal infection show enhanced 
ability to secrete IFNγ when compared to CD8  T cells obtained from day 14 infected mice (33). 
cells capable of producing IFN-γ, however unlike with the murine hepatitis virus (148) there is 
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 no indication of an epitope shift.  It should also be noted that upon antigenic stimulation 2D5 
cells can kill as well as secrete IFNγ.   
Therefore in the present study we attempted to answer the following important questions; 
whether or not IFNγ can block HSV-1 reactivation from latency and if perforin mediated 
cytolytic mechanisms are necessary for CD8+ T cells to confer such exquisite protection.  Our 
findings (Section 4.5.1) demonstrated that rIFNγ cannot block HSV-1 reactivation from latency 
when added at the initiation of day 35 TG cultures. (Recent data in our lab indicates that some 
neurons are susceptible to IFNγ control while others are not). Clearly, the TG cultures differ in 
many ways from the in vivo TG. For instance, the neurons are undoubtedly stressed during 
excision, which might compromise their intrinsic ability to inhibit HSV-1 gene expression. In 
addition, the CD8+ T cells are separated from the latently infected neurons until contact can be 
reestablished in culture. Moreover, the cytokines that are produced by the CD8+ T cells may be 
diluted and washed away more rapidly in ex vivo cultures than they are in the TG in situ. We 
believe the inability of endogenous CD8+ T tells in day 35 TG or rIFNγ to block HSV-1 
reactivation might reflect some of these changes that occur in the TG upon excision. We 
proposed that a brief treatment of TG cultures with ACV might alleviate these problems by 
pushing the reactivating HSV-1 genomes back into the latent state that existed prior to TG 
excision and providing the CD8+ T cells time to reestablish contact with infected neurons and to 
be activated.  ACV treatment did render latently infected neurons susceptible to IFNγ inhibition 
of HSV-1 reactivation. Inhibition of HSV-1 reactivation was only observed when latently 
infected neurons were exposed to IFNγ within 24 h after ACV removal from cultures. This 
observation suggests that IFNγ blocks an early step in HSV-1 reactivation from latency. The 
rIFNγ was less effective at blocking HSV-1 reactivation when endogenous CD8+ T cells were 
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 depleted from the day 35 TG cells. Furthermore, addition of 2D5 cells to day 35 C57BL/6 
cultures provided protection from reactivation without the addition of ACV (Figure 24 and 26) 
indicating the likelihood that CD8+ T cells utilize more than one mechanism to block HSV-1 
reactivation.  However, the effectiveness of IFNγ was not further compromised by depletion of 
all bone marrow-derived cells from the TG cultures. Thus, IFNγ appears to inhibit HSV-1 
reactivation in part through augmentation of a CD8+ T cell response.   
IFNγ delayed and reduced HSV-1 reactivation in day 35 TG cultures that were depleted 
of all detectable CD45+ cells. The latter observation suggested that IFNγ can also directly inhibit 
HSV-1 reactivation in neurons. To our knowledge, this is the first direct demonstration that IFNγ 
can block HSV-1 reactivation from latency in neurons. In vivo studies comparing wild-type and 
IFNγ knockout (GKO) mice on a BALB/c background demonstrated more rapid reactivation of 
HSV-1 from latency following induction by hyperthermic stress (190) or UV-B corneal 
irradiation (191) in GKO mice. In the former study the overall incidence of reactivation was also 
increased in IFNγ deficient mice, whereas this difference was not observed in the latter study. 
Another recent study using an in vivo reactivation model with GKO mice on C57BL/6 
background demonstrated that IFNγ was critical in preventing reactivation and subsequently 
death of HSV-1 infected mice (192).  Our findings with the ex vivo model of HSV-1 reactivation 
from latency in sensory neurons are in good general agreement with in vivo studies using mice 
with targeted disruption of the IFNγ gene. Moreover, our model avoids the complication of 
differences in control of the acute infection, establishment of latency, and possible compensatory 
mechanisms in GKO mice, and should facilitate studies of latency at the molecular level.   
The mechanism by which IFNγ prevents HSV-1 reactivation is not yet known.  During 
lytic infections, IFNγ has been shown to inhibit expression of ICP4, a potent transactivator of 
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 HSV gene expression, destabilize HSV mRNA, and stabilize HSV-1 association with nuclear 
protein aggregates called ND10 bodies, which inhibit HSV-1 gene expression (193,194). Any of 
these mechanisms could contribute to the effect of IFNγ on HSV-1 reactivation in neurons, 
although ND10 bodies have been difficult to detect in neurons (195).  Recent studies have 
identified an immediate early viral protein ICP0, which can block IFNγ function by inhibiting 
interferon induced gene expression (12,13).  Using in vitro assays the inhibition by ICP0 was 
depend
diated 
mechan
ent on its level of expression in infected cells.  Thus, it is reasonable to suggest that in ex 
vivo TG cultures (and perhaps in vivo), the effectiveness of IFNγ would likely depend on the 
level as well as the timing of the cytokine expression.   During a reactivation event the level of 
viral gene expression may reach a critical point where elevated concentration of ICP0 may 
render IFNγ ineffective at maintaining viral latency (especially if timely expression of IFNγ is 
not achieved).  This would explain the need for IFNγ early in reactivation. In such an event, 
IFNγ independent mechanism(s) (i.e. perforin) are likely to play a critical role in blocking HSV-
1 reactivation.  However, whether or not ICP0 functions with the same efficiency in neurons was 
not tested.   
To determine if lytic granule-mediated mechanisms are important in blocking HSV-1 
reactivaion from latency, we evaluated the ability of PfP CD8+ T cells to protect HSV-1 
reactivation in ex vivo TG cultures.  To this end we first compared reactivation frequencies in 
PfP and WT TG cultures at 14 days PI.  CD8+ T cells present in the TG at the time of excision in 
PfP mice were incapable of inhibiting HSV-1 reactivation from latency, where as those present 
in WT TG blocked reactivation with greater efficiency. This suggested that a perforin-me
ism was important in preventing reactivation early during latency.  As mentioned above, 
the stress induced by explanting TGs can trigger events that can lead to HSV-1 reactivation in 
106 
 certain neurons, which may artificially increase the need for cytolytic mechanisms to prevent full 
reactivation.  For this reason we treated day 14 cultures with ACV for 4 days in order to truly 
evaluate the requirement of perforin for maintaining viral latency.  Treatment of PfP and WT 
cultures with ACV yielded similar results confirming the need for perforin in maintaining 
latency at 14 days after HSV-1 corneal infection.   However, the need for perforin in day 34 TG 
cultures was not as dramatic.  Although, reactivation was delayed in WT TG cultures , by 14 
days in culture, reactivation frequencies of PfP and WT mice were similar, although reactivation 
was delayed in WT TG cultures.  Moreover, supplementing WT and PfP cultures with rIFNγ 
completely alleviated the need for perforin.  Interestingly in day 34 TG cultures that lacked viral 
reactivation IFNγ levels in supernatants reached their peak at 8 days after culture initiation but 
began to decline soon thereafter.  At the time when IFNγ levels began to drop WT cultures 
started reactivating suggesting the importance of IFNγ in preventing reactivation at 34 days PI.  
These results confirm our hypothesis that granule-mediated mechanisms are indeed essential in 
preventing HSV reactivation early during latency when a greater array of viral proteins are 
expressed, but non-lytic mechanisms such as IFNγ secretion are more important at 34 days PI 
when a more stable viral latency is established.  Moreover, attempts to detect MHC class I 
proteins on TG neurons at 34 days PI have failed, however at 14 days PI MHC class I molecules 
were readily detectable on neurons suggesting the possibility of elevated viral gene expression at 
14 days PI which may coincide with MHC class I expression.   
These data raise interesting questions about how CD8+ T cells might deal with virus 
infections in sensory neurons that cannot be regenerated, and what factors determine which 
aspects of the CD8+ T cell functional program are exerted.  There is evidence in humans and 
mice that HSV-1 corneal infection is associated with partial loss of corneal sensation, suggesting 
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 that some neurons are killed either by the virus or by immune mechanisms (196).  However, we 
have not noticed immunopathology in latently infected TG, and our previous studies clearly 
established that CD8+ T cells can block HSV-1 reactivation from latency in TG cultures by a 
non-lytic mechanism(s) (32,33).  In fact, a gB498-505 specific CD8+ T cell clone that is both 
cytotoxic and produces IFN-γ when stimulated was able to block HSV-1 reactivation from 
latency in TG cultures without eliminating the latently infected neurons.   
Epitope density is one factor that has been proposed as a differential signal for CD8+ T 
cell expression of non-cytotoxic (i.e., IFN-γ) or cytotoxic (i.e., lytic granule release) effector 
mechanisms (197-200).  The apparent immunologic synapse formation between CD8+ T cells 
and neurons within latently infected TG suggests that the neurons are able to express the gB498-
505 epitope that is recognized by the T cell receptor on these cells.  Neurons up-regulate MHC 
class I expression during HSV-1 lytic infection 138,139, but MHC class I expression diminishes 
to an undetectable level when the virus enters a latent state.  This suggests concordant regulation 
of MHC class I and viral gene expression in neurons.  We propose that under conditions that 
permit the viral genome to emerge from a quiescent state MHC class I gene expression is 
concomitantly initiated.  Thus viral proteins that are expressed early in reactivation are processed 
and presented with MHC class I at an initial low density on the surface of the neuron.  The 
epitope density would increase as reactivation progressed.  A recent study demonstrated that the 
gB498-505 epitope is expressed on cells very early (within 2 hours) after a lytic infection is initiated 
128, and may also be expressed early during reactivation.  We propose that exposure of gB498-505 
specific CD8+ T cells to neurons early in reactivation, when the gB498-505 epitope density would 
presumably be low, would induce IFN-γ production but not lytic granule release by the CD8+ T 
cells (Figure 48).  In contrast, encounter of CD8+ T cells with a neuron late in the reactivation 
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 process, when gB498-505 epitope density would be high might result in induction of the entire 
functional program of the CD8+ T cells, including lytic granule release.  The susceptibility of the 
neurons to apoptosis induction by the lytic granules might be determined by the level of 
accumulation of viral LATs or proteins such as the US3 and US5 that inhibit apoptosis 
(201,202).   
An alternative explanation for the differential use by CD8+ T cells of lytic and non-lytic 
mechanisms to control HSV-1 reactivation from latency might lie in the observation that 
memory CD8+ T cells lose granzyme B expression, but maintain expression of IFN-γ (77).  
Memory CD8+ T cells regain granzyme B expression upon stimulation.  Thus, lytic granule 
release by CD8+ T cells might only be possible if IFN-γ fails to rapidly shut down HSV-1 gene 
expression during reactivation.   
Regulation either by epitope density or through loss of granzyme B would accommodate 
the use of non-lytic mechanisms early in reactivation and lytic mechanisms late in reactivation.  
A recent report demonstrated that only very rare neurons (1 in every 10 latently infected mouse 
TG) express viral γ2 genes (29).  These rare neurons were surrounded by leukocytes and 
appeared to be dying.  In contrast, our studies demonstrated that most HSV-1 specific CD8+ T 
cells in latently infected TG express an activation phenotype and exhibit TCR polarization 
toward junctions with multiple neurons (33), and the neurons appeared healthy.  These findings 
are consistent with the notion that CD8+ T cells normally block HSV-1 reactivation in neurons 
through a non-lytic mechanism, but can kill those rare neurons that reach a late stage of HSV-1 
reactivation and are refractory to non-lytic mechanisms. 
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In the present study, we examined the requirement of IL-15 and IL-2 during the expansion 
and memory
 
5.3. How do IL-2 and IL-15 Regulate T cell responses in the TG after HSV-1 Infection 
 
 phases of T cell responses in non-lymphoid (sensory ganglion) and secondary 
lympho
aracterized by a robust T cell response in the sensory ganglion 
and s +
phoid sites during 
the lytic and latent phase of a viral infection. 
In vitro studies have determined IL-2 as essential for T cell proliferation (162), however, 
its requirement in vivo for T cell expansion and memory, after viral infections is still unclear.  
id tissues after HSV-1 corneal infection.  HSV-1 infection provides us with a unique 
model to study how cytokines influence lymphoid and extra-lymphoid T cell responses.  After 
HSV-1 corneal infection in mice the virus briefly replicates in the corneal epithelium followed 
by retrograde axonal transport to the body of the neuronal cell in the trigeminal ganglion (TG) 
where it establishes a latent infection.  Recent data from our lab demonstrated that HSV-1 latent 
infection is a dynamic process ch
ustained immunosurveillance by CD8  T cells long after the establishment of latency.  
There is considerable evidence to suggest persistent viral gene expression and antigen 
presentation during HSV-1 latency (33,29,22).  Although, recent studies have investigated the 
role of IL-15 and IL-2 in the expansion, and memory phases of T cell responses following acute 
viral infections, the understanding of how these cytokines function in an environment of constant 
viral antigen presentation and infrequent reactivation in tertiary tissues is limited.  Two recent 
studies elegantly showed that the immune response to an antigenic challenge is not limited to the 
secondary lymphoid organs; in actuality a large percentage of antigen-specific T cells migrate to 
tertiary tissues (81,82).  The current study adds new dimensions to our understanding of how IL-
15 and IL-2 regulate T cell responses in lymphoid organs as well as non-lym
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 Experiments with IL-2-/- and CD25-/- (IL-2Rα-/-) mice have yielded puzzling results that are 
difficult to interpret since these mice rapidly develop severe autoimmune diseases (203,204,165).  
of IL-2 during primary CD8+ T cell expansion was examined by 
adopt
al high affinity IL-15Rα and IL-2Rα.  We avoided 
the co
In a recent study, the role 
ive transfer of IL-2-/- and IL-2Rα-/- OT-1 TCR transgenic CD8+ T cells (specific for OVA) 
into normal hosts. The mice were then infected with recombinant VSV that expressed soluble 
OVA.  IL-2-/- and IL-2Rα-/- OT-1 cells expanded normally in secondary lymphoid organs, but 
failed to expand adequately in the intestinal lamina propria (LP). The reduced CD8+ T cell 
expansion in the LP was attributed to a lack of sustained cell division during primary responses 
to VSV-OVA    (97,99).  However, another study reached a different conclusion (173).  They 
used CD122-/- (IL-2Rβ-/-) transgenic mice (Tg-/-) that are resistant to autoimmune disorders 
normally associated with non-transgenic IL2Rβ-/- mice.  Tg-/- mice were immunized with OVA in 
complete Freund’s adjuvant (CFA) and primary and secondary CD8+ T cell responses were 
evaluated.  CD8+ T cell responses were normal in Tg-/- mice after immunization with OVA, 
suggesting that IL-2 or IL-15 were not essential for CD8+ T cell expansion in lymphoid tissues.  
Both of these studies used transgenic mouse models that may render interpretation of results 
difficult.  Adoptive transfer of a large number of naïve OT-1-TCR transgenic CD8+ T cells can 
dramatically increase the precursor frequency and may alter the true requirements of cytokines in 
vivo.  Moreover, TCR transgenic CD8+ T cells were isolated from four week old IL-2-/- and IL-
Rα-/- OT-1 mice that develop serious lymphoproliferative diseases, although later than in non 
transgenic IL-2-/- mice.  Primary CD8+ T cell responses in Tg -/- mice were measured after 
administration of soluble OVA in CFA and not after a natural viral infection. Additionaly, Tg -/- 
mice have CD8+ T cells that express function
mplexities associated with using such mouse models by employing a simpler approach.  To 
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 assess IL-2 function we used a monoclonal antibody (95) to block IL-2 during the expansion 
phase of CD8+ T cell response after HSV-1 corneal infection.  In addition IL-15-/- mice were 
used to examine the role of IL-15 during primary and memory phases of T cell responses to 
HSV-1 infection.   Since we were particularly interested in determining the requirement of IL-2 
during the primary T cell response in the TG, we delayed the administration of anti-IL-2 Ab until 
day 6 PI; this is after the CD8+ T cell response peaks in the lymph nodes (124), but just prior to 
the maximum CD8+ T cell expansion in the TG (between day 6 and 8 PI).  Both CD8+ and CD4+ 
T cell numbers were dramatically reduced in IL-15-/- mice and in WT mice that received only 
one injection of anti-IL-2 antibody. Intriguingly, both viral specific and antigen independent 
CD8+ T cells were negatively affected by the lack of IL-15 or IL-2. The effect however, was 
more pronounced in viral specific CD8+ T cells.  This suggested that both IL-2 and IL-15 are 
essential for T cell expansion in tertiary tissues like the sensory ganglion.  We further show that 
there are notable differences in the effect of IL-15 and IL-2 on lymphoid vs. non-lymphoid T 
cells.  In contrast to the TG, CD4+ and CD8+ T cell expansion in the lymph nodes between 6 and 
8 days PI was not affected by the treatment of anti-IL2 antibody.  However, as in the TG, CD8+ 
T cell expansion in the lymph node was significantly reduced in IL-15-/- mice at 5 and 8 days 
after corneal infection.  Interestingly CD4+ T cell expansion in the LN of IL-15-/- mice was 
normal.  These data are in agreement with D’Souza et.al who showed that lack of IL-2 function 
lead to a reduction in CD8+ T cell response only in tertiary tissues but not in secondary lymphoid 
organs (97,99).   
Our results clearly show that IL-15 is vital for primary ganglionic CD8+ and CD4+ T cell 
responses as well as lymphoid CD8+ T cell expansion. Antigen specific CD8+ T cell response in 
the TG was severely compromised in IL-15-/- mice as well as mice that received anti-IL2 
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 antibody; there was an 80% drop in the number of antigen specific CD8+ T cells retained in the 
TG at 8 days after corneal infection. These findings suggest an even greater dependence on IL-15 
and IL-2 by CD8+ T cells in non-lymphoid tissues.  Conversely, IL-15 was not required for CD4+ 
T cell response in the lymph nodes.  Contrary to our findings in the TG, other researchers have 
found that IL-15 does not play any role in CD4+ T cell responses (102). However, none of the 
studies thus far have examined the effect of IL-15 on non-lymphoid CD4+ T cells after viral 
infections.   
Our conclusions about the positive regulation of IL-15 in initial proliferation of lymphoid 
CD8+ T cells are at odds with recent reports that did not find any correlation with IL-15 and 
primary CD8+ T cell expansion (169,100).  There are important differences between the infection 
models used in the above studies that may explain the conflicting results.  Mice in the 
aforementioned studies were infected systemically (intravenous injections) with LCMV (169) or 
VSV (100).  Because LCMV directly infects secondary lymphoid organs a systemic infection 
with it results in an unusually large CD8+ T cell burst size; where more than 80% of the 
lymphoid CD8+ T cells are viral specific (78).  It is likely that such an extraordinary 
inflammatory response leads to elevated expression of other cytokines and chemokines that can 
alter the requirements of IL-15.  HSV-1 corneal infection is a localized mucosal infection that 
does not lead to viral replication in the lymphoid organs (126).  Furthermore, at the peak of the 
immune response in the LNs only 2% of the CD8+ T cells are viral specific at 5 days PI in the 
draining lymph nodes.   
  IL-2 and IL-15 share the same β and γ chain cytokine receptors and both cytokines can 
exert positive effects on T cell expansion. To determine if deficiency in both cytokines would 
further weaken primary T cell responses, we blocked IL-2 function between day 6 and 8 PI in IL-
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 15-/- mice.  We consistently observed a more pronounced reduction in antigen specific CD8+ T 
cell numbers in anti-IL-2 treated IL-15-/- mice compared to IL-15-/- mice alone, however, the 
reduction was not statistically significant.  Although, simultaneously blocking IL-2 and IL-15 did 
not result in a significant drop in T cell responses in LN or TG, we hypothesize that IL-15 and 
IL-2 may function sequentially. There is evidence that IL-15 can enhance IL-2Rα (CD25) 
expression on CD8+ T cells (205), however the effect of IL-2 on CD25 expresion is controversial 
(205,168).   
A possible explanation for the lack of optimal T cell response during the expansion phase 
of the immune response in the TG and LN of IL-15 -/- and anti-IL-2 treated mice could be 
decreased proliferation, an increase in apoptosis or a combination of the two.  In WT mice there 
is an 8 fold increase in ganglionic CD8+ T cell numbers between day 6 and 8 after HSV-1 
corneal infection.  To assess the level of T cell proliferation in the TG and LNs, we treated mice 
with BrdU at day 6 and 7 PI.  Lymphoid CD8+ T cell proliferation was indeed compromised in 
IL-15-/- mice but was normal in anti-IL-2 treated WT mice, suggesting that IL-15 contributes to 
the proliferation of anti viral CD8+ T cells in the LNs during the expansion phase of an immune 
response. On the contrary, the percentage of CD8+ T cells that incorporated BrdU in the TG 
between 6 and 8 days PI was normal in all three groups of mice.  Thus, the dysregulation in the 
level of CD8+ T cell response in the TG was not due to impaired proliferation.  An alternative 
explanation for the weak T cell expansion phase could be a reduction in sustained turnover of T 
cells in the absence of IL-2 and IL-15.  A similar conclusion was reached by a recent study in 
which IL-2R-/- CD8+ T cells underwent fewer divisions after antigenic challenge compared to 
those from WT mice (99).    
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 Why should there be notable differences in the way cytokines regulate T cell responses in 
lymphoid vs. non lymphoid tissues?  We believe that antigen dose may dictate the level of 
requirement for IL-15.  Early during a viral infection the level of antigen presentation is high and 
this initial antigen encounter by T cells can trigger early rounds of cell division but as the virus is 
cleared from the body, sustained T cell proliferation may become increasingly dependent on IL-
15 and (or) IL-2.  After an HSV-1 infection there is no evidence of replicating virus in the LN, 
however the virus does travel to the TG where it briefly replicates and by day 8 majority of the 
replic
igration of CD8+ and CD4+ T cells to the TG is adversely affected 
by the lack of IL-2 and IL-15.  However, at day 6 PI we did not observe any significant 
ating virus is cleared.  It is conceivable that a lack of replicating virus in the LN leads to a 
milieu of limited antigen dose where CD8+ T cell proliferation is highly dependent on IL-15.  In 
the TG at 6 days PI replicating virus is readily available to initiate T cell division but in the 
subsequent 24 to 48 hours the presence of cytokines becomes increasingly important for 
sustaining cellular division.  There are other important differences between lymphoid and non-
lymphoid tissues that can also contribute to the observed differences in the T cell responses after 
HSV-1 infection.  (i) The cytokine milieu in the LN may be quite different compared to the 
sensory ganglia.  (ii) The context in which the cytokines are presented to receptors on T cells 
may be different in non-lymphoid tissues; there is evidence that cytokines such as IL-2 can bind 
to the extracellular matrix in extra-lymphoid tissues (206,207).  (iii) CD8+ T cells in the TG 
compared to the LN may differ phenotypically and (or) functionally.  We are currently 
examining the IL-2 and IL-15 receptor expression on lymphoid and ganglionic CD8+ T cells in 
order to discern tissue specific phenotypic differences.   Recent reports have also implicated IL-
15 and IL-2 in regulating T cell migration and homing to sites of infection (208,209,210), 
likewise it is possible that m
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 differences in the number of T cells present in the TG.  To address some of the issues mentioned 
above, an adoptive transfer study with CFSE labeled CD8+ T cells will be done. 
In our present study we made the additional important observation: an unusually high 
degree of bystander CD8+ T cell activation in the TG.  At 8 days after corneal infection more 
than 50% of the gB-dimer negative CD8+ T cells in the TG incorporated BrdU, and in the lymph 
nodes a majority of the dividing CD8+ T cells were antigen-independent.  This putative 
bystander activation of CD8+ T cells was severely diminished by the lack of IL-15.  While IL-15 
has been shown to promote CD44hi memory CD8+ T cell proliferation in an antigen-independent 
manner (103,170,211,212), a role for IL-15 in regulating bystander activation-induced 
proliferation of naïve and memory CD8+ T cells during the course of infection has not been 
demonstrated.  Bystander activation appears to be more prominent after a localized infection 
with HSV-1 compared to a systemic infection with LCMV.  After an LCMV infection more than 
80% of the responding CD8+ T cells are viral specific.  However, 5 days after HSV-1 corneal 
infection, viral specific CD8+ T cells account for only 2% of all CD8+ T cells present in the LN.  
A recent in vitro study with human T cells favors such a possibility (213).     
IL-2 and IL-15 can negatively regulate T cell death; however we did not observe any 
preferential increase in apoptotic potential of CD8+ T cells in the TG at 8 days PI. However, 
detecting apoptotic cells in extra-lymphoid tissues is difficult, given that apoptotic cells are 
cleared immediately by phagocytes even before the exposure of PS on the cell surface. 
Moreover, collagenase treatment and the harsh physical breakup of TG in to single cell 
suspensions can result in non-specific exposure of PS in otherwise non apoptotic (Annexin-V-) T 
cells.  We also examined the level of CD8+ T cell death in the lymph nodes.  There was elevated 
CD8+ T cell apoptosis in IL-15-/- mice, but surprisingly the highest percentage of apoptotic CD8+ 
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 T cells was found in anti-IL-2 treated IL-15-/- mice (>30% of CD8+ T cells).  We conclude that 
IL-15 contributes to the survival of antigen specific and bystander CD8+ T cells in LNs. In 
additi
ze of virus-specific 
memor
on, blocking IL-2 and IL-15 simultaneously increases effector CD8+ T cell death and 
thereby accelerates the contraction phase of lymphoid CD8+ T cell response after HSV-1 corneal 
infection.  
Our data are consistent with recent findings that IL-15 is essential for the maintenance of 
memory CD8+ T cells retained in secondary lymphoid organs (169,100,102,170).  The present 
study adds another dimension to the understanding of the role of IL-15 in regulating memory T 
cells during a latent/persistent infection.  We show that IL-15 is necessary to prevent attrition of 
viral specific memory CD8+ T cells in non-lymphoid sites such as the TG.   Interestingly, CD4+ 
T cell numbers were also notably reduced in the TGs of IL-15-/- mice at 65 days PI but splenic 
CD4+ T cell numbers were normal.  To our knowledge this is the first report that has examined 
the effect of IL-15 on CD4+ and CD8+ T cells in extra-lymphoid tissues during the primary and 
memory phases of an anti-viral immune response.   
The current paradigm that initial clonal burst size determines the si
y CD8+ T cell population is largely based on studies performed with lymphoid T cell 
populations (78,214,215).  Our findings are consistent with this paradigm with one important 
exception.  As noted earlier, anti-IL-2 treated mice showed a dramatic decrease (20% of normal) 
in the number of effector CD8+ T cells at the peak of the immune response in the TG after HSV-
1 corneal infection. Yet, this reduction in effector CTL expansion did not result in a smaller 
memory CD8+ T cell pool.  Thus, at least in the TG it appears that the magnitude of HSV- 
specific memory CD8+ T cell pool is not dependent on the initial burst size.  In addition, the 
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 CD8+ T cells that became memory cells do not require the presence of IL-2 during the expansion 
phase of an anti-viral response. 
How does our current study impact our understanding of the immune response during an 
HSV infection?  We have previously shown that there is a constant T cell monitoring of HSV-1 
gene expression during latency.  After HSV-1 corneal infection T cells are recruited to the TG in 
great n
ent normally associated with 
chronic
 
 
 
 
 
umbers and are subsequently retained in the tissue for the life of the animal. CD8+ T cells 
exhibit an activation phenotype, and combined with the juxtaposition of CD8+ T cells with 
neuron cell bodies in latently infected TG suggests a condition of constant antigen presentation 
which can lead to T cell exhaustion or anergy as seen in other chronic/persistent infections 
(160,216,217,218,219).  Human studies with HIV patients have revealed that one explanation for 
the impairment of the CD8+ T cell adaptive immune response during the course of HIV infection 
is the dysregulated production of IL-15 as well as IL-2.   Therefore, we believe that IL-2 and 
particularly IL-15 play a pivotal role in the expansion of effector cell in tertiary tissues, and in 
preventing ganglionic T cell exhaustion and functional impairm
 infections.   Recently we demonstrated that IFNγ appears to inhibit HSV-1 reactivation 
in part through augmentation of a CD8+ T cell response, furthermore, several laboratories have 
observed a uniform expression of IFN-γ and TNF-α in latently infected TG (22,136,129,135). 
Upregulation of IL-15 expression by IFNγ (103,211) in the TG may very well be one of the 
means IFNγ augments CD8+ T cell responses during latency.   
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Figure 47: Summary of events in the TG.  After HSV-1 infection, CD8+ T cells go through the 
typical expansion and contraction phase in the TG.  By day 34 PI a stable pool of memory CD8  
T cell is established.  Anti IL-2 treated mice (at day 6 PI) have a reduced expansion phase, but 
form a normal memory CD8
+
   
igure 48: Summary of events in the lymphoid organs. After HSV-1 corneal infection, CD8+ T 
ells in the LN go through the typical expansion and contraction phase.  By day 34 PI a stable 
ool of memory CD8+ T cell is established.  Anti IL-2 treated mice (at day 6 PI) go through a 
ormal expansion phase, as well as form a normal memory CD8+ T cell pool.  IL-15-/- mice have 
 reduced expansion phase, and fail to form a normal memory CD8+ T cell population in the 
pleen. 
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+ T cell pool.  IL-15-/- mice have a reduced expansion phase and fail 
to form a normal memory CD8+ T cell population. 
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 Considering the data presented in this study, we propose that after HSV-1 corneal 
infection, corneal langerhan and dentritic cells interact with T cells in secondary lymphoid 
organs leading to the primary T cell expansion, which is 5 (mainly for 
CD8+ T cells) but IL-2 independent.  Activated T cells migrate to the TG (Figure 47 and 48) 
where they con to divide (as result of replicating virus), and this subsequent 
expansion/survival is mediated by IL-2 and (or) IL Next follows the contraction phase 
where a majority of the CD8+  survive and are retained in an 
activated state for the life of the ani ctor cells expressing high levels of 
In conclusion, our findings have confirmed and added to the understanding of how 
effector and memory T cells responses are controlled by d IL-15 in secondary lymphoid 
and non-lymphoid tertiary tissues.  In addition we cha rrent tenets underlying the 
role of IL-15, which are based on observations of events occurring in lymphoid organs after 
acute viral infections that are readily cleared from the body.  We demonstrate a novel role of IL-
15 in regulating primary and m ry CD4 e also 
demonstrate that IL-15 is necessary for CD8+ T cell expansion in the lymph nodes as well as in 
the TG after HSV-1 corneal infecti m that IL-15 prevents attrition of 
mory D8+ T cells in lymphoid in addition to non-lymphoid sites.   
 
 in part dependent on IL-1
tinue 
-15.  
 T cells die and a fraction of them
mal. It is possible that effe
IL-7 receptor but not IL-2R (220) survive to bemome memory CD8  T cells.  The maintenance 
of memory T cells is highly dependent on IL-15 even in the face of continual antigen 
presentation.  
+
 
 IL-2 an
llenge the cu
+ T cell responses in non-lymphoid tissues.  Wemo
on. And finally we confir
me  C
 
 
120 
  
6. SUMMARY 
Parts of Section 6 are modified from the article titled “Immunity to latent viral infection: 
many skirmishes but few fatalities” submitted to Trends in Immunology. 
 
infected branch of the TG, where they provide active surveillance of HSV-1 gene 
 
The body of work presented in this thesis has greatly advanced our understanding of HSV 
infections.  Our findings are leading to a paradigm shift in our conception of HSV-1 latency from 
a virus/neuron relationship to a tripartite interaction involving the virus, neuron, and host 
immunity.  In this study we have provided clear evidence that HSV-1 latency does not represent 
a silent infection that is ignored by the host immune system.  To the contrary, we demonstrate 
that after HSV-1 corneal infection there is an antigen-directed retention of memory CD8+ T cells 
in the latently 
expression.  The expansion and retention of T cells in the TG after HSV-1 infection is in part 
regulated by IL-2 and IL-15.  Finally we also show that CD8+ T cells can prevent viral 
reactivation from latency in sensory neurons by IFNγ and perforin mediated mechanisms.  Based 
on the data presented here we propose a model of immune surveillance during HSV-1 latency 
and reactivation (Figure 49).  
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 Figure 49: Model of immune surveillance during HSV-1 latency and reactivation. 
(A) Although HSV-1 can replicate efficiently in mouse sensory neurons, spontaneous reactivation 
from latency with virion formation as seen in other species (i.e., humans, rabbits, etc) does not 
occur in mouse sensory ganglia.  However, we propose that at any given time in an HSV-1 
latently infected mouse trigeminal ganglion, multiple neurons express viral α, β, and even γ1 
gene products, which are rapidly processed to peptides and presented in the context of MHC I on 
the neuron surface (1).  In C57BL/6 mice, HSV-1 α, and β gene products are ignored by CD8+ T 
cells, but an immunodominant epitope on the HSV-1 γ1 gene product, gB binds to the CD8+ T 
cell receptor (2).  Since gB and MHC I are likely to be expressed at a low level early in 
reactivation, a low density of these gB/MHC class I complexes might selectively induce IFN-γ 
+ γ
expression of γ2 genes and vir
production by CD8  T cells (3).  At this stage in reactivation, IFN-  can block progression to 
ion formation (4, 5).  The neuron is not destroyed, but the virus is 
pushed back into a more stable state of latency. 
 that encounter with a neuron at a late stage of reactivation will activate the full 
functional program of CD8+ T cells for two reasons.  From a teleological standpoint, the 
inability of IFN-γ to regulate viral gene expression late in the viral life cycle would require 
CD8+ T cells to employ an alternative mechanism to prevent virion formation (1,2).  From a 
mechanistic standpoint we propose that as the reactivation process progresses, the density of 
gB/MHC I complexes increases on the surface of the neuron (3).  Thus, a CD8+ T cell that 
encounters a neuron late in the reactivation process might receive strong TCR stimulation from 
a high epitope density, leading to activation of both IFN-γ production (4,5) and lytic granule 
release (6), potentially inducing apoptosis (7).  The capacity of the neuron to survive this 
encounter might depend on the level of accumulation of anti-apoptotic viral proteins such as 
US3 and US5. 
 
(B) We propose
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 Since recurrent HSV-1 disease results from reactivation of latent virus as opposed to 
exogenous re-infection, these findings have important implications for vaccine developm
We propose that a vaccine that targets the CD8+ T cells that are retained in the latently inf
sensory ganglia might be efficacious in preventing recurrent herpetic disease.  A viral α
product, ICP47 inhibits antigen presentation to CD8+ T cells more efficiently in humans than in 
ce (189). We propose that a more efficient CD8+ T cell response to HSV-1 might account for 
ent.  
ected 
 gene 
mi
 
e 
D8+ T cell 
haracterized by expression of IFNγ, TNFα and chemokines such as IP-10 and 
RANTES.   
the lack of spontaneous HSV-1 reactivation in mice.  By extension, increasing the efficiency of 
the CD8+ T cell response might have a similar effect in humans.  Clearly the HSV vaccines
tested to date have had disappointing efficacy in humans.  However, a therapeutic vaccin
containing epitopes that are expressed early in HSV-1 reactivation might augment C
protection from reactivation, while minimizing destruction of sensory neurons.  An interesting 
caveat is that periodic reactivation in neurons and shedding of virus might enhance immunity at 
peripheral sites, preventing exogenous re-infection.  Thus, an effective vaccine might have to 
target both reactivation of virus from latency in sensory ganglia and lytic infection at peripheral 
sites.   
We are elated by emerging data from human studies in our and other labs that confirm 
our findings in the mouse model (Figure 50) (118,119,221).  A recent study published in the 
American Journal of Pathology found a similar infiltration of CD8+ T cells in human TGs 
latently infected with HSV-1 (222).  The CD8+ T cells were in close apposition to neurons that 
expressed viral LATs, in contrast uninfected or VZV infected TGs shown little or no T cell 
infiltrate.  In addition, quantitative RT-PCR of infected TGs revealed elevated levels of 
inflammation c
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Figure 50: CD8  T cell infiltrate found in human TGs of individuals infected with HSV-1.  
Paraffin embedded human TGs (kindly provided by Dr. Y. Jerold Gordon) were stained with 
purified anti-human CD8, followed by biotin-conjugated secondary antibody.  Horse raddish 
peroxidase ABC kit was used to detect the secondary antibody.  Note that many CD8+ T cells 
(arrows) are in close apposition to neuronal cell bodies (white arrow heads).  We also noticed 
clusters of T cells surrounding neurons in a few field of views (right pictogram); perhaps 
indicating a reactivation event. 
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